Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Gastroesophageal Cancer | Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer (Companion Faculty Lecture)
|
May 03, 2024 |
Gastroesophageal Cancer | Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
|
May 03, 2024 |
Myelofibrosis | Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
|
May 02, 2024 |
Endometrial Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Endometrial Cancer
|
May 01, 2024 |
Paroxysmal Nocturnal Hemoglobinuria | Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
|
Apr 26, 2024 |
Prostate Cancer | Oncology Today with Dr Neil Love: Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium
|
Apr 25, 2024 |
Myeloproliferative Neoplasms | Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from Recent Major Conferences
|
Apr 24, 2024 |
Pancreatic Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Colorectal Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Hepatobiliary Cancers | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Gastroesophageal Cancers | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Multiple Myeloma | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Nontargeted Treatments for Lung Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Targeted Therapy for Non-Small Cell Lung Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Prostate Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Urothelial Bladder Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Renal Cell Carcinoma | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Metastatic HER2-Positive and Triple-Negative Breast Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Localized Breast Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Gynecologic Cancers | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Hodgkin and Non-Hodgkin Lymphoma | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
ER-Positive Metastatic Breast Cancer | Third Annual National General Medical Oncology Summit
|
Apr 19, 2024 |
Ovarian Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Ovarian Cancer
|
Apr 17, 2024 |
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition (Companion Faculty Lecture)
|
Apr 16, 2024 |
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gastrointestinal Cancers — Part 2 of a Special 3-Part Edition
|
Apr 16, 2024 |
Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia from Recent Major Conferences
|
Apr 12, 2024 |
Colorectal Cancer | Arvind Dasari, MD, MS
|
Apr 08, 2024 |
Colorectal Cancer | Thierry André, MD
|
Apr 08, 2024 |
Colorectal Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
|
Apr 08, 2024 |
Urothelial Bladder Cancer | Thomas Powles, MBBS, MRCP, MD
|
Apr 05, 2024 |
Urothelial Bladder Cancer | Shilpa Gupta, MD
|
Apr 05, 2024 |
Urothelial Bladder Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Urothelial Bladder Cancer
|
Apr 05, 2024 |
B7-H3-Targeted Antibody-Drug Conjugates | Oncology Today with Dr Neil Love: The Emerging Role of B7-H3-Targeted Antibody-Drug Conjugates
|
Apr 04, 2024 |
Prostate Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
|
Mar 28, 2024 |
Prostate Cancer | Andrew J Armstrong, MD, ScM
|
Mar 28, 2024 |
Prostate Cancer | Maha Hussain, MD, FACP, FASCO
|
Mar 28, 2024 |
Lymphoma | Andrew M Evens, DO, MBA, MSc
|
Mar 27, 2024 |
Lymphoma | Sonali M Smith, MD
|
Mar 27, 2024 |
Lymphoma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Lymphoma
|
Mar 27, 2024 |
ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Overcoming Endocrine Resistance in ER-Positive Metastatic Breast Cancer
|
Mar 26, 2024 |
Hepatobiliary Cancers | Consensus or Controversy? Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers — A 2024 Post-ASCO Gastrointestinal Cancers Symposium Review
|
Mar 21, 2024 |
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
|
Mar 20, 2024 |
HER2-Positive and Triple-Negative Breast Cancer | Priyanka Sharma, MD
|
Mar 15, 2024 |
HER2-Positive and Triple-Negative Breast Cancer | Ian E Krop, MD, PhD
|
Mar 15, 2024 |
HER2-Positive and Triple-Negative Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
|
Mar 15, 2024 |
Metastatic Urothelial Bladder Cancer | Virtual Case Library: Metastatic Urothelial Bladder Cancer
|
Mar 13, 2024 |
ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer (Companion Faculty Lecture)
|
Mar 11, 2024 |
ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer
|
Mar 11, 2024 |
Myelofibrosis | Meet The Professor: Optimizing the Management of Myelofibrosis — Part 1 of a 2-Part Series
|
Mar 08, 2024 |
Gastroesophageal Cancers | Yelena Y Janjigian, MD
|
Mar 07, 2024 |
Gastroesophageal Cancers | Zev Wainberg, MD, MSc
|
Mar 07, 2024 |
Gastroesophageal Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gastroesophageal Cancers
|
Mar 07, 2024 |
Chronic Lymphocytic Leukemia | Jeff Sharman, MD
|
Feb 27, 2024 |
Chronic Lymphocytic Leukemia | Lindsey Roeker, MD
|
Feb 27, 2024 |
Chronic Lymphocytic Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
|
Feb 27, 2024 |
Hepatobiliary Cancers | Consensus or Controversy? Investigator Perspectives on the Current and Future Role of Immune Checkpoint Inhibitors in the Management of Hepatobiliary Cancers
|
Feb 23, 2024 |
Prostate Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer
|
Feb 20, 2024 |
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4 of a 4-Part Series
|
Feb 16, 2024 |
Colorectal Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on Biomarker Assessment and Related Treatment Decision-Making for Patients with Colorectal Cancer
|
Feb 15, 2024 |
Urothelial Bladder Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Urothelial Bladder Cancer
|
Feb 09, 2024 |
Gastroesophageal Cancers | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Gastroesophageal Cancers
|
Feb 07, 2024 |
Hormone Receptor-Positive Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hormone Receptor-Positive Breast Cancer
|
Feb 01, 2024 |
Hormone Receptor-Positive Breast Cancer | Erica Mayer, MD, MPH, FASCO
|
Feb 01, 2024 |
Hormone Receptor-Positive Breast Cancer | Stephanie L Graff, MD, FACP
|
Feb 01, 2024 |
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3 of a 4-Part Series
|
Jan 24, 2024 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 3 of a 3-Part Series
|
Jan 17, 2024 |
Multiple Myeloma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Multiple Myeloma
|
Jan 10, 2024 |
Diffuse Large B-Cell Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Diffuse Large B-Cell Lymphoma
|
Jan 08, 2024 |
HER2-Low Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of HER2-Low Breast Cancer
|
Jan 04, 2024 |
Chronic Lymphocytic Leukemia | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Chronic Lymphocytic Leukemia
|
Jan 03, 2024 |
HER2-Negative Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Localized HER2-Negative Breast Cancer
|
Dec 28, 2023 |
Follicular, Mantle Cell and Hodgkin Lymphoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Follicular, Mantle Cell and Hodgkin Lymphoma
|
Dec 27, 2023 |
ER-Positive Metastatic Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of ER-Positive Metastatic Breast Cancer
|
Dec 21, 2023 |
Gynecologic Cancers | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Gynecologic Cancers — Part 1 of a Special 3-Part Edition
|
Dec 20, 2023 |
Biliary Tract Cancer | Inside the Issue: Targeted and Immunotherapeutic Approaches for Biliary Tract Cancers
|
Dec 14, 2023 |
Biliary Tract Cancer | Milind Javle, MD
|
Dec 14, 2023 |
Biliary Tract Cancer | Lipika Goyal, MD, MPhil
|
Dec 14, 2023 |
Lung Cancer | Implications of Recent Data Sets for the Current and Future Management of Lung Cancer
|
Dec 11, 2023 |
Non-Small Cell Lung Cancer | Aaron Lisberg, MD
|
Dec 11, 2023 |
Non-Small Cell Lung Cancer | Luis Paz-Ares, MD, PhD
|
Dec 11, 2023 |
Non-Small Cell Lung Cancer | Zofia Piotrowska, MD, MHS
|
Dec 11, 2023 |
Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3 of a 3-Part Series
|
Dec 06, 2023 |
Breast Cancer | Implications of Recent Data Sets for the Current and Future Management of Breast Cancer
|
Nov 30, 2023 |
Gynecologic Cancers | Implications of Recent Data Sets for the Current and Future Management of Gynecologic Cancers
|
Nov 21, 2023 |
Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2 of a 3-Part Series
|
Nov 15, 2023 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 2 of a 3-Part Series
|
Nov 10, 2023 |
HER2-Positive and Triple-Negative Breast Cancer | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Nov 03, 2023 |
Multiple Myeloma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Nov 03, 2023 |
Gynecologic Cancers | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Nov 03, 2023 |
Hepatobiliary and Pancreatic Cancers | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Nov 03, 2023 |
Urothelial Bladder Cancer and Renal Cell Carcinoma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Nov 03, 2023 |
Lymphoma | Oncology in the Real World: A Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Nov 03, 2023 |
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2 of a 4-Part Series
|
Nov 02, 2023 |
Chronic Lymphocytic Leukemia | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Oct 27, 2023 |
Colorectal and Gastroesophageal Cancers | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Oct 27, 2023 |
Non-Small Cell Lung Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Oct 27, 2023 |
Prostate Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Oct 27, 2023 |
ER-Positive Breast Cancer | Current Approaches and Future Strategies in Oncology: A Multitumor Educational Symposium in Partnership with Florida Cancer Specialists & Research Institute
|
Oct 27, 2023 |
Diffuse Large B-Cell Lymphoma | Cases from the Community: Investigators Discuss the Application of Available Research in the Care of Patients with Diffuse Large B-Cell Lymphoma
|
Oct 26, 2023 |
Nonmelanoma Skin Cancer | Nikhil I Khushalani, MD
|
Oct 25, 2023 |
Nonmelanoma Skin Cancer | Anna C Pavlick, DO, MBA
|
Oct 25, 2023 |
Nonmelanoma Skin Cancer | Inside the Issue: Optimizing the Management of Nonmelanoma Skin Cancer
|
Oct 25, 2023 |
Gastroesophageal Cancer | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1 of a 3-Part Series
|
Oct 23, 2023 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes — Part 1 of a 3-Part Series
|
Oct 20, 2023 |
Mantle Cell Lymphoma | What Clinicians Want to Know About the Management of Relapsed/Refractory Mantle Cell Lymphoma
|
Oct 19, 2023 |
Multiple Myeloma | Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from Recent Major Oncology/Hematology Conferences
|
Oct 18, 2023 |
Lung Cancer | John V Heymach, MD, PhD
|
Oct 16, 2023 |
Lung Cancer | Jamie E Chaft, MD
|
Oct 16, 2023 |
Lung Cancer | Inside the Issue: Integrating Targeted and Immunotherapy into the Management of Localized Non-Small Cell Lung Cancer
|
Oct 16, 2023 |
Pancreatic Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Pancreatic Cancer with Dr Michael Pishvaian
|
Oct 13, 2023 |
Non-Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma with Dr Matthew Matasar
|
Oct 12, 2023 |
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1 of a 4-Part Series
|
Oct 10, 2023 |
Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma (Companion Faculty Lecture)
|
Oct 09, 2023 |
Multiple Myeloma | What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma
|
Oct 09, 2023 |
Colorectal Cancer | Practical Perspectives: Investigators Discuss Current Management and Actual Cases of Relapsed/Refractory Metastatic Colorectal Cancer
|
Oct 06, 2023 |
Colorectal Cancer | J Randolph Hecht, MD
|
Oct 06, 2023 |
Colorectal Cancer | Kristen K Ciombor, MD, MSCI
|
Oct 06, 2023 |
Blastic Plasmacytoid Dendritic Cell Neoplasm | Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm
|
Oct 05, 2023 |
Blastic Plasmacytoid Dendritic Cell Neoplasm | Oncology Today with Dr Neil Love: Blastic Plasmacytoid Dendritic Cell Neoplasm (Companion Faculty Lecture)
|
Oct 05, 2023 |
Myelofibrosis | Consensus or Controversy? Documenting and Discussing Clinical Investigators’ Practice Patterns in Myelofibrosis
|
Oct 04, 2023 |
Breast Cancer | Hope S Rugo, MD
|
Sep 29, 2023 |
Breast Cancer | Tiffany A Traina, MD, FASCO
|
Sep 29, 2023 |
Breast Cancer | Inside the Issue: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
|
Sep 29, 2023 |
Multiple Myeloma | Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma
|
Sep 28, 2023 |
Multiple Myeloma | Oncology Today with Dr Neil Love: Emerging Role of CELMoDs (Cereblon E3 Ligase Modulators) and Other Novel Approaches to Targeting Protein Degradation Pathways in Multiple Myeloma (Companion Faculty Lecture)
|
Sep 28, 2023 |
Ovarian Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian Cancer
|
Sep 26, 2023 |
Ovarian Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in the Treatment of Ovarian Cancer (Companion Faculty Lecture)
|
Sep 26, 2023 |
Hematologic Oncology | What Clinicians Want to Know About Toxicity Considerations Associated with BTK Inhibitors
|
Sep 22, 2023 |
Pancreatic Cancer | Zev Wainberg, MD, MSc
|
Sep 18, 2023 |
Pancreatic Cancer | Eileen M O’Reilly, MD
|
Sep 18, 2023 |
Pancreatic Cancer | Inside the Issue: Optimizing the Management of Metastatic Pancreatic Cancer
|
Sep 18, 2023 |
Non-Hodgkin Lymphoma | Martin Hutchings, MD, PhD
|
Sep 14, 2023 |
Non-Hodgkin Lymphoma | Loretta J Nastoupil, MD
|
Sep 14, 2023 |
Non-Hodgkin Lymphoma | Inside the Issue: The Current and Future Role of CD20 x CD3 Bispecific Antibodies in the Management of Non-Hodgkin Lymphoma
|
Sep 14, 2023 |
Melanoma | Meet The Professor: Optimizing the Management of Melanoma
|
Sep 12, 2023 |
Lung Cancer | Striving for Consensus: Current and Future Management of Metastatic Non-Small Cell Lung Cancer in Patients Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy
|
Sep 08, 2023 |
Hepatocellular Carcinoma | The Implications of Recent Data Sets for the Management of Hepatocellular Carcinoma
|
Sep 06, 2023 |
Prostate Cancer | Neal D Shore, MD
|
Sep 01, 2023 |
Prostate Cancer | Inside the Issue: Exploring the Current and Future Management of High-Risk, Hormone-Sensitive Nonmetastatic Prostate Cancer
|
Sep 01, 2023 |
Mantle Cell Lymphoma | Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma
|
Aug 31, 2023 |
Mantle Cell Lymphoma | Oncology Today with Dr Neil Love: Role of BTK Inhibitors in Patients with Mantle Cell Lymphoma (Companion Faculty Lecture)
|
Aug 31, 2023 |
Soft Tissue Sarcoma | Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 2 of a 2-Part Series
|
Aug 30, 2023 |
Chronic Lymphocytic Leukemia and Lymphoma | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences
|
Aug 29, 2023 |
Chronic Lymphocytic Leukemia and Lymphoma | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Chronic Lymphocytic Leukemia and Lymphoma from Recent Major Oncology/Hematology Conferences (Companion Faculty Lecture)
|
Aug 29, 2023 |
Genitourinary Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Genitourinary Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 25, 2023 |
Breast Cancer | Inside the Issue: Current and Future Management of ER-Positive Metastatic Breast Cancer After Disease Progression on a CDK4/6 Inhibitor
|
Aug 24, 2023 |
Breast Cancer | Erika Hamilton, MD
|
Aug 24, 2023 |
Breast Cancer | Aditya Bardia, MD, MPH
|
Aug 24, 2023 |
Multiple Myeloma | Inside the Issue: Integrating Bispecific Antibodies into the Management of Multiple Myeloma — Patient Selection and Toxicity Management
|
Aug 23, 2023 |
Multiple Myeloma | Hans Lee, MD
|
Aug 23, 2023 |
Multiple Myeloma | Saad Zafar Usmani, MD, MBA
|
Aug 23, 2023 |
Lung Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 22, 2023 |
Lung Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Lung Cancer from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Companion Faculty Lecture)
|
Aug 22, 2023 |
Melanoma and Nonmelanoma Skin Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
|
Aug 17, 2023 |
Melanoma and Nonmelanoma Skin Cancers | Evan J Lipson, MD
|
Aug 17, 2023 |
Melanoma and Nonmelanoma Skin Cancers | Omid Hamid, MD
|
Aug 17, 2023 |
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gastrointestinal Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Companion Faculty Lecture)
|
Aug 16, 2023 |
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gastrointestinal Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 16, 2023 |
Prostate Cancer | Ready for Prime Time? Determining the Current and Future Role of PARP Inhibitor-Based Combinations in the Management of Prostate Cancer
|
Aug 14, 2023 |
Gynecologic Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting (Companion Faculty Lecture)
|
Aug 11, 2023 |
Gynecologic Cancers | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Gynecologic Cancers from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
|
Aug 11, 2023 |
Urothelial Bladder Cancer | Inside the Issue: Optimizing the Management of Metastatic Urothelial Bladder Cancer
|
Aug 10, 2023 |
Urothelial Bladder Cancer | Terence Friedlander, MD
|
Aug 10, 2023 |
Urothelial Bladder Cancer | Petros Grivas, MD, PhD
|
Aug 10, 2023 |
Breast Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting on Breast Cancer
|
Aug 08, 2023 |
Higher-Risk Myelodysplastic Syndromes | David Sallman, MD
|
Aug 02, 2023 |
Higher-Risk Myelodysplastic Syndromes | Guillermo Garcia-Manero, MD
|
Aug 02, 2023 |
Higher-Risk Myelodysplastic Syndromes | Inside the Issue: Novel Agents, Approaches and Strategies in the Management of Higher-Risk Myelodysplastic Syndromes
|
Aug 02, 2023 |
Immune Thrombocytopenia | Oncology Today with Dr Neil Love: Management of Immune Thrombocytopenia (Faculty Lecture)
|
Jul 31, 2023 |
Immune Thrombocytopenia | Oncology Today with Dr Neil Love: Management of Immune Thrombocytopenia
|
Jul 31, 2023 |
Chronic Lymphocytic Leukemia | What I Tell My Patients: New Treatments and Clinical Trials — Chronic Lymphocytic Leukemia
|
Jul 28, 2023 |
Paroxysmal Nocturnal Hemoglobinuria | Oncology Today with Dr Neil Love: Management of Paroxysmal Nocturnal Hemoglobinuria (Faculty Lecture)
|
Jul 26, 2023 |
Paroxysmal Nocturnal Hemoglobinuria | Oncology Today with Dr Neil Love: Management of Paroxysmal Nocturnal Hemoglobinuria
|
Jul 26, 2023 |
Renal Cell Carcinoma | Investigator Perspectives on Available Research Findings and Challenging Questions in Renal Cell Carcinoma
|
Jul 17, 2023 |
Endometrial Cancer | The Implications of New Research Findings for the Management of Endometrial Cancer
|
Jul 14, 2023 |
Gastroesophageal Cancers | Lunch with the Investigators: Gastroesophageal Cancers
|
Jul 13, 2023 |
Prostate Cancer | Second Opinion: Investigators Discuss How They and Their Colleagues Apply Available Clinical Research in the Care of Patients with Prostate Cancer
|
Jul 12, 2023 |
Hodgkin and Non-Hodgkin Lymphoma | Meet The Professor: The Current and Future Management of Hodgkin and Non-Hodgkin Lymphoma
|
Jul 10, 2023 |
Colorectal and Gastroesophageal Cancers | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Colorectal and Gastroesophageal Cancers
|
Jul 07, 2023 |
Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma | Meet The Professors Live: Clinical Investigators Provide Perspectives on Actual Cases of Patients with Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma
|
Jul 05, 2023 |
Urothelial Bladder Cancer | Breakfast with the Investigators: Urothelial Bladder Cancer
|
Jun 30, 2023 |
Hepatobiliary Cancers | Breakfast with the Investigators: Hepatobiliary Cancers
|
Jun 29, 2023 |
Ovarian Cancer | Breakfast with the Investigators: Ovarian Cancer
|
Jun 27, 2023 |
Video Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Breast Cancer
|
Jun 26, 2023 |
What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Urothelial Bladder Cancer
|
Jun 22, 2023 |
What I Tell My Patients: Faculty Physicians and Nurses Discuss the Role of Antibody-Drug Conjugates in the Management of HER2-Expressing Cancers Across the Oncology Spectrum
|
Jun 21, 2023 |
Video Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Non-Small Cell Lung Cancer
|
Jun 20, 2023 |
What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Diffuse Large B-Cell Lymphoma
|
Jun 19, 2023 |
Meet The Professor: Optimizing the Management of Soft Tissue Sarcoma and Related Connective Tissue Disorders — Part 1 of a 2-Part Series
|
Jun 16, 2023 |
What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Acute Myeloid Leukemia, Myelodysplastic Syndromes and Myelofibrosis
|
Jun 15, 2023 |
What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Prostate Cancer
|
Jun 12, 2023 |
Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 3 of a 3-Part Series
|
Jun 08, 2023 |
What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Ovarian Cancer
|
Jun 06, 2023 |
Oncology Today with Dr Neil Love — HER2-Positive Metastatic Breast Cancer
|
Jun 01, 2023 |
Urothelial Bladder Cancer | Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Urothelial Bladder Cancer
|
May 31, 2023 |
What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Hepatobiliary Cancers
|
May 30, 2023 |
Chronic Lymphocytic Leukemia | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Chronic Lymphocytic Leukemia
|
May 25, 2023 |
Prostate Cancer | Beyond The Guidelines: Urologic Oncology Investigators Provide Perspectives on the Optimal Management of Prostate Cancer
|
May 24, 2023 |
Lung Cancer | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Lung Cancer
|
May 22, 2023 |
Biliary Tract Cancers — Richard S Finn, MD
|
May 19, 2023 |
Hepatobiliary Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary Cancers
|
May 19, 2023 |
Hepatocellular Carcinoma — Ghassan Abou-Alfa, MD, MBA
|
May 19, 2023 |
Breast Cancer | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Breast Cancer
|
May 17, 2023 |
Cervical and Endometrial Cancer | What I Tell My Patients: Faculty Physicians and Nurses Discuss Patient Education About New Treatments and Clinical Trials — Cervical and Endometrial Cancer
|
May 11, 2023 |
Colorectal Cancer | Pashtoon M Kasi, MD, MS
|
May 09, 2023 |
Colorectal Cancer | Wells A Messersmith, MD
|
May 09, 2023 |
Colorectal Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Colorectal Cancer
|
May 09, 2023 |
Prostate Cancer | Oncology Today: Recent Research Advances in Prostate Cancer and the Clinical Implications – A 2023 Post-ASCO GU Activity
|
May 05, 2023 |
Prostate Cancer | Daniel P Petrylak, MD
|
May 05, 2023 |
Non-Small Cell Lung Cancer | Luis Paz-Ares, MD, PhD
|
May 01, 2023 |
Non-Small Cell Lung Cancer | Heather Wakelee, MD
|
May 01, 2023 |
Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
|
May 01, 2023 |
Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 3
|
Apr 27, 2023 |
Endometrial Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Endometrial Cancer
|
Apr 26, 2023 |
Myelodysplastic Syndromes | Uma Borate, MD, MS
|
Apr 21, 2023 |
Acute Myeloid Leukemia | Andrew H Wei, MBBS, PhD
|
Apr 21, 2023 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|
Apr 21, 2023 |
Multiple Myeloma | Oncology Today with Dr Neil Love: Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting — Multiple Myeloma Edition
|
Apr 19, 2023 |
Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Renal Cell Carcinoma and Bladder Cancer
|
Apr 17, 2023 |
Urothelial Bladder Cancer | Matthew Milowsky, MD
|
Apr 17, 2023 |
Renal Cell Carcinoma | Thomas Powles, MBBS, MRCP, MD
|
Apr 17, 2023 |
Ovarian Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Ovarian Cancer
|
Apr 14, 2023 |
Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Key Presentations from the 64th American Society of Hematology (ASH) Annual Meeting — Chronic Lymphocytic Leukemia Edition
|
Apr 12, 2023 |
Colorectal Cancer | Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 2 of a 3-Part Series
|
Apr 07, 2023 |
Prostate Cancer | A Oliver Sartor, MD
|
Apr 06, 2023 |
Prostate Cancer | Tanya B Dorff, MD
|
Apr 06, 2023 |
Prostate Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
|
Apr 06, 2023 |
Gastroesophageal and Hepatobiliary Cancers | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Gastroesophageal and Hepatobiliary Cancers — A 2023 Post-ASCO GI Webcast
|
Apr 04, 2023 |
Hepatobiliary Cancers | Lipika Goyal, MD, MPhil
|
Apr 04, 2023 |
Gastroesophageal Cancers | Zev Wainberg, MD, MSc
|
Apr 04, 2023 |
Breast Cancer | Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 2 of a 3-Part Series
|
Mar 31, 2023 |
Urothelial Bladder Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Urothelial Bladder Cancer
|
Mar 30, 2023 |
Prostate Cancer | Investigators Discuss Available Research Guiding the Care of Patients with Prostate Cancer
|
Mar 23, 2023 |
Ovarian Cancer and Tumor Treating Fields | Oncology Today with Dr Neil Love — Role of PARP Inhibition in Ovarian Cancer and Recent Data with Tumor Treating Fields
|
Mar 22, 2023 |
Hepatobiliary Cancers | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Hepatobiliary Cancers
|
Mar 21, 2023 |
Lung Cancer | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 17, 2023 |
Gynecologic Cancers | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 17, 2023 |
Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 17, 2023 |
Genitourinary Cancers | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 17, 2023 |
Gastrointestinal Cancers | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 17, 2023 |
Breast Cancer | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 17, 2023 |
Renal Cell Carcinoma | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Renal Cell Carcinoma
|
Mar 16, 2023 |
Colorectal Cancer | Meet The Professor: Optimizing the Management of Colorectal Cancer — Part 1 of a 3-Part Series
|
Mar 14, 2023 |
Breast Cancer | Ann Partridge, MD, MPH
|
Mar 10, 2023 |
Breast Cancer | Kathy Miller, MD
|
Mar 10, 2023 |
Breast Cancer | Inside the Issue — Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
|
Mar 10, 2023 |
Gastroesophageal Cancers | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Gastroesophageal Cancers
|
Mar 07, 2023 |
Lung Cancer | Striving for Consensus on the Management of ALK-Positive Lung Cancer
|
Mar 06, 2023 |
Lymphomas | Oncology Today with Dr Neil Love: Key Presentations in Hodgkin and Non-Hodgkin Lymphomas from the 2022 ASH Annual Meeting
|
Mar 02, 2023 |
Desmoid Tumors | Oncology Today with Dr Neil Love: Management of Desmoid Tumors (Companion Faculty Lecture)
|
Feb 28, 2023 |
Desmoid Tumors | Oncology Today with Dr Neil Love: Management of Desmoid Tumors
|
Feb 28, 2023 |
ER-Positive and Triple-Negative Breast Cancer | Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 1 of a 3-Part Series
|
Feb 24, 2023 |
BTK Inhibitors | Inside the Issue — Optimizing the Management of Adverse Events Associated with BTK Inhibitors
|
Feb 23, 2023 |
Colorectal Cancer | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Colorectal Cancer
|
Feb 22, 2023 |
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of HER2-Altered Non-Small Cell Lung Cancer
|
Feb 21, 2023 |
Hodgkin and Non-Hodgkin Lymphomas | Laurie H Sehn, MD, MPH
|
Feb 18, 2023 |
Hodgkin and Non-Hodgkin Lymphomas | Christopher R Flowers, MD, MS
|
Feb 18, 2023 |
Hodgkin and Non-Hodgkin Lymphomas | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hodgkin and Non-Hodgkin Lymphomas
|
Feb 18, 2023 |
Thyroid Cancer and Neuroendocrine Tumors | Oncology Today with Dr Neil Love — Thyroid Cancer and Neuroendocrine Tumors
|
Feb 15, 2023 |
Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 4
|
Feb 14, 2023 |
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation (Companion Faculty Lecture)
|
Feb 13, 2023 |
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Non-Small Cell Lung Cancer without an Actionable Mutation
|
Feb 13, 2023 |
Myeloproliferative Neoplasms | Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2022 ASH Annual Meeting
|
Feb 09, 2023 |
Gynecologic Oncology | Krishnansu S Tewari, MD
|
Feb 08, 2023 |
Gynecologic Oncology | Kathleen N Moore, MD, MS
|
Feb 08, 2023 |
Gynecologic Oncology | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
|
Feb 08, 2023 |
Diffuse Large B-Cell Lymphoma | Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma (Companion Faculty Lecture)
|
Feb 06, 2023 |
Diffuse Large B-Cell Lymphoma | Oncology Today with Dr Neil Love: Advances in Diffuse Large B-Cell Lymphoma
|
Feb 06, 2023 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Key Presentations in Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2022 ASH Annual Meeting
|
Feb 02, 2023 |
Multiple Myeloma | Ajay K Nooka, MD, MPH
|
Feb 01, 2023 |
Multiple Myeloma | Joseph Mikhael, MD, MEd
|
Feb 01, 2023 |
Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
|
Feb 01, 2023 |
Breast Cancer | Oncology Today with Dr Neil Love: Special Edition — Management of ER-Positive Breast Cancer
|
Jan 31, 2023 |
Breast Cancer | Oncology Today with Dr Neil Love: HER2-Positive Metastatic Breast Cancer (Companion Video Lecture)
|
Jan 26, 2023 |
Breast Cancer | Oncology Today with Dr Neil Love: HER2-Positive Metastatic Breast Cancer
|
Jan 26, 2023 |
Targeted Therapy in Non-Small Cell Lung Cancer | Gregory J Riely, MD, PhD
|
Jan 24, 2023 |
Targeted Therapy in Non-Small Cell Lung Cancer | Zofia Piotrowska, MD, MHS
|
Jan 24, 2023 |
Targeted Therapy for Non-Small Cell Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
|
Jan 24, 2023 |
Chronic Lymphocytic Leukemia | Deborah Stephens, DO
|
Jan 20, 2023 |
Chronic Lymphocytic Leukemia | Jennifer R Brown, MD, PhD
|
Jan 20, 2023 |
Chronic Lymphocytic Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
|
Jan 20, 2023 |
Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 3
|
Jan 19, 2023 |
Breast Cancer | Joyce O’Shaughnessy, MD
|
Jan 17, 2023 |
Breast Cancer | Professor Peter Schmid, FRCP, MD, PhD
|
Jan 17, 2023 |
Breast Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Breast Cancer
|
Jan 17, 2023 |
Acute Myeloid Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia
|
Jan 13, 2023 |
Acute Myeloid Leukemia | Courtney D DiNardo, MD, MSCE
|
Jan 13, 2023 |
Acute Myeloid Leukemia | Andrew H Wei, MBBS, PhD
|
Jan 13, 2023 |
Gastroesophageal Cancers | Oncology Today with Dr Neil Love: Management of Gastroesophageal Cancers (Companion Faculty Lecture)
|
Jan 12, 2023 |
Gastroesophageal Cancers | Oncology Today with Dr Neil Love: Management of Gastroesophageal Cancers
|
Jan 12, 2023 |
Multiple Myeloma | Addressing Current Questions and Controversies in the Management of Multiple Myeloma — What Clinicians Want to Know
|
Jan 11, 2023 |
Hodgkin and Non-Hodgkin Lymphoma | Addressing Current Questions and Controversies in the Management of Hodgkin and Non-Hodgkin Lymphoma — What Clinicians Want to Know
|
Jan 09, 2023 |
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Managing Metastatic Urothelial Bladder Cancer (Companion Faculty Lecture)
|
Jan 05, 2023 |
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Managing Metastatic Urothelial Bladder Cancer
|
Jan 05, 2023 |
ER-Positive Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of ER-Positive Breast Cancer
|
Jan 04, 2023 |
Chronic Lymphocytic Leukemia | Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia — What Clinicians Want to Know
|
Dec 28, 2022 |
HER2-Positive Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of HER2-Positive Breast Cancer
|
Dec 22, 2022 |
Ovarian Cancer | Oncology Today with Dr Neil Love: Role of PARP Inhibition in Ovarian Cancer (Companion Faculty Lecture)
|
Dec 21, 2022 |
Ovarian Cancer | Oncology Today with Dr Neil Love: Role of PARP Inhibition in Ovarian Cancer
|
Dec 21, 2022 |
Non-Small Cell Lung Cancer | Alexander I Spira, MD, PhD
|
Dec 16, 2022 |
Non-Small Cell Lung Cancer | Helena Yu, MD
|
Dec 16, 2022 |
Non‑Small Cell Lung Cancer | Emerging Role of Antibody‑Drug Conjugates in the Management of Non‑Small Cell Lung Cancer
|
Dec 16, 2022 |
Multiple Myeloma | BCMA-Directed Therapy in Multiple Myeloma: Expert Opinions and Patient Perspectives — Part 2
|
Dec 15, 2022 |
Melanoma | Oncology Today with Dr Neil Love: Novel Immunotherapeutic Strategies in Melanoma (Companion Faculty Lecture)
|
Dec 13, 2022 |
Melanoma | Oncology Today with Dr Neil Love: Novel Immunotherapeutic Strategies in Melanoma
|
Dec 13, 2022 |
Thyroid Cancer | Oncology Today with Dr Neil Love: Thyroid Cancer (Companion Faculty Lecture)
|
Dec 08, 2022 |
Thyroid Cancer | Oncology Today with Dr Neil Love: Thyroid Cancer
|
Dec 08, 2022 |
Meet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 2
|
Dec 07, 2022 |
Amyloid Light Chain (AL) Amyloidosis | Oncology Today with Dr Neil Love: Amyloid Light Chain (AL) Amyloidosis (Companion Faculty Lecture)
|
Dec 06, 2022 |
Amyloid Light Chain (AL) Amyloidosis | Oncology Today with Dr Neil Love: Amyloid Light Chain (AL) Amyloidosis
|
Dec 06, 2022 |
Acute Myeloid Leukemia | Oncology Today with Dr Neil Love — Novel Agents and Strategies in AML
|
Dec 05, 2022 |
Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 2
|
Dec 02, 2022 |
Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis (Companion Faculty Lecture)
|
Dec 01, 2022 |
Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis
|
Dec 01, 2022 |
Ovarian Cancer | Consensus or Controversy? Current and Future Management of Ovarian Cancer
|
Nov 30, 2022 |
Renal Cell Carcinoma | Oncology Today with Dr Neil Love: Management of Renal Cell Carcinoma (Companion Faculty Lecture)
|
Nov 29, 2022 |
Renal Cell Carcinoma | Oncology Today with Dr Neil Love: Management of Renal Cell Carcinoma
|
Nov 29, 2022 |
Non-Small Cell Lung Cancer | Stephen V Liu, MD
|
Nov 28, 2022 |
Non-Small Cell Lung Cancer | John V Heymach, MD, PhD
|
Nov 28, 2022 |
Non-Small Cell Lung Cancer | Current Paradigm and Future Directions for Immunotherapy in the Treatment of Metastatic Non-Small Cell Lung Cancer
|
Nov 28, 2022 |
Breast Cancer | Meet The Professor: Optimizing the Management of HER2-Positive Breast Cancer — Part 3
|
Nov 22, 2022 |
Hepatocellular Carcinoma | Oncology Today with Dr Neil Love: Management of Hepatocellular Carcinoma (Companion Faculty Lecture)
|
Nov 21, 2022 |
Hepatocellular Carcinoma | Oncology Today with Dr Neil Love: Management of Hepatocellular Carcinoma
|
Nov 21, 2022 |
Acute Myeloid Leukemia | Oncology Today with Dr Neil Love: Novel Agents and Strategies in AML
|
Nov 17, 2022 |
Acute Myeloid Leukemia | Oncology Today with Dr Neil Love: Novel Agents and Strategies in AML (Companion Faculty Lecture)
|
Nov 17, 2022 |
Melanoma | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
Gastrointestinal Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
Ovarian Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
Endometrial Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
Breast Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
Hepatobiliary Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
Multiple Myeloma | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
Renal Cell Carcinoma | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
Prostate and Bladder Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
Lung Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with Florida Cancer Specialists
|
Nov 16, 2022 |
Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Higher-Risk Myelodysplastic Syndromes
|
Nov 15, 2022 |
Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Higher-Risk Myelodysplastic Syndromes (Companion Faculty Lecture)
|
Nov 15, 2022 |
Multiple Myeloma| BCMA-Directed Therapy in Multiple Myeloma: Expert Opinions and Patient Perspectives — Part 1
|
Nov 11, 2022 |
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Key Presentations Related to Gastrointestinal Cancers from Recent Major Oncology Conferences (Companion Faculty Lecture)
|
Nov 10, 2022 |
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Key Presentations Related to Gastrointestinal Cancers from Recent Major Oncology Conferences
|
Nov 10, 2022 |
Prostate Cancer | Meet The Professor: Optimizing the Use of Hormonal Therapy in the Management of Prostate Cancer — Part 1
|
Nov 09, 2022 |
Chronic Lymphocytic Leukemia | Challenging Cases from Junior Investigators: The Application of Available and Emerging Clinical Research in the Care of Patients with Chronic Lymphocytic Leukemia
|
Nov 08, 2022 |
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of MET-Altered Non-Small Cell Lung Cancer (Companion Faculty Lecture)
|
Nov 07, 2022 |
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of MET-Altered Non-Small Cell Lung Cancer
|
Nov 07, 2022 |
Myelofibrosis | Oncology Today with Dr Neil Love: Current Management of Myelofibrosis (Companion Faculty Lecture)
|
Nov 03, 2022 |
Myelofibrosis | Oncology Today with Dr Neil Love: Current Management of Myelofibrosis
|
Nov 03, 2022 |
Neuroendocrine Tumors | Oncology Today with Dr Neil Love: Neuroendocrine Tumors (Companion Faculty Lecture)
|
Nov 01, 2022 |
Neuroendocrine Tumors | Oncology Today with Dr Neil Love: Neuroendocrine Tumors
|
Nov 01, 2022 |
Non-Small Cell Lung Cancer | Meet The Professor: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation — Part 3
|
Oct 31, 2022 |
Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 1
|
Oct 28, 2022 |
Melanoma | Oncology Today with Dr Neil Love: BRAF-Mutant Metastatic Melanoma
|
Oct 27, 2022 |
Melanoma | Oncology Today with Dr Neil Love: BRAF-Mutant Metastatic Melanoma (Companion Faculty Lecture)
|
Oct 27, 2022 |
Diffuse Large B-Cell Lymphoma | Challenging Cases from the Community: Investigators Provide Perspectives on the Optimal Management of Diffuse Large B-Cell Lymphoma
|
Oct 26, 2022 |
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of RET Fusion-Positive Non-Small Cell Lung Cancer (Companion Video Lecture)
|
Oct 25, 2022 |
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of RET Fusion-Positive Non-Small Cell Lung Cancer
|
Oct 25, 2022 |
Breast Cancer | Meet The Professor: Optimizing the Management of HER2-Positive Breast Cancer — Part 2
|
Oct 21, 2022 |
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Nonmetastatic Urothelial Bladder Cancer (Companion Faculty Lecture)
|
Oct 20, 2022 |
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Nonmetastatic Urothelial Bladder Cancer
|
Oct 20, 2022 |
Myelodysplastic Syndromes | Exploring Current Considerations and Promising Investigational Approaches for Patients with Myelodysplastic Syndromes
|
Oct 19, 2022 |
Small Cell Lung Cancer | Meet The Professor: Optimizing the Management of Small Cell Lung Cancer — Part 2
|
Oct 17, 2022 |
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 5
|
Oct 13, 2022 |
Head and Neck and Thyroid Cancers | Meet The Professor: Optimizing the Management of Head and Neck and Thyroid Cancers
|
Oct 11, 2022 |
Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Patients with Small Cell Lung Cancer
|
Oct 06, 2022 |
Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Patients with Small Cell Lung Cancer (Companion Faculty Lecture)
|
Oct 06, 2022 |
Oncology Today: Management of Endometrial Cancer
|
Oct 04, 2022 |
Multiple Myeloma | Oncology Today with Dr Neil Love: BCMA-Directed Therapies for Multiple Myeloma (Companion Faculty Lecture)
|
Sep 29, 2022 |
Multiple Myeloma | Oncology Today with Dr Neil Love: BCMA-Directed Therapies for Multiple Myeloma
|
Sep 29, 2022 |
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Localized Non-Small Cell Lung Cancer (Companion Faculty Lecture)
|
Sep 26, 2022 |
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Localized Non-Small Cell Lung Cancer
|
Sep 26, 2022 |
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 4
|
Sep 23, 2022 |
Breast Cancer | Meet The Professor: Optimizing the Management of HER2-Positive Breast Cancer — Part 1
|
Sep 22, 2022 |
Non-Small Cell Lung Cancer | Meet The Professor: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation — Part 2
|
Sep 20, 2022 |
Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Current and Future Management of Hodgkin Lymphoma (Companion Faculty Lecture)
|
Sep 15, 2022 |
Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Current and Future Management of Hodgkin Lymphoma
|
Sep 15, 2022 |
Interstitial Lung Disease | Oncology Today with Dr Neil Love: Interstitial Lung Disease in Patients Receiving Anticancer Therapy (Companion Faculty Lecture)
|
Sep 13, 2022 |
Interstitial Lung Disease | Oncology Today with Dr Neil Love: Interstitial Lung Disease in Patients Receiving Anticancer Therapy
|
Sep 13, 2022 |
Small Cell Lung Cancer | Meet The Professor: Optimizing the Management of Small Cell Lung Cancer — Part 1
|
Sep 09, 2022 |
Endometrial Cancer | Oncology Today with Dr Neil Love: Endometrial Cancer Edition (Companion Faculty Lecture)
|
Sep 08, 2022 |
Endometrial Cancer | Oncology Today with Dr Neil Love: Endometrial Cancer Edition
|
Sep 08, 2022 |
Gastroesophageal Cancers | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 5
|
Sep 07, 2022 |
Oncology Today with Dr Neil Love: Ocular Toxicities in Patients Receiving Anticancer Therapy (Companion Faculty Lecture)
|
Sep 06, 2022 |
Ocular Toxicities | Oncology Today with Dr Neil Love: Ocular Toxicities in Patients Receiving Anticancer Therapy
|
Sep 06, 2022 |
Non-Small Cell Lung Cancer | Meet The Professor: Non-Small Cell Lung Cancer with an Actionable Target Beyond EGFR — Part 4
|
Sep 02, 2022 |
Hematologic Cancers | Data + Perspectives: Investigators Discuss the Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies in the Care of Patients with Hematologic Cancers
|
Sep 01, 2022 |
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 3
|
Aug 31, 2022 |
Lung Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Aug 25, 2022 |
Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Aug 25, 2022 |
Multiple Myeloma | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Aug 25, 2022 |
Genitourinary Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Aug 25, 2022 |
Breast Cancer | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Aug 25, 2022 |
Lung Cancer | Oncology Today with Dr Neil Love: Key Presentations in Lung Cancer from the 2022 ASCO Annual Meeting (Companion Faculty Lecture)
|
Aug 24, 2022 |
Lung Cancer | Oncology Today with Dr Neil Love: Key Presentations in Lung Cancer from the 2022 ASCO Annual Meeting
|
Aug 24, 2022 |
Gastrointestinal Cancers | Proceedings from a Daylong Multitumor Educational Symposium in Partnership with the American Oncology Network
|
Aug 18, 2022 |
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: KRAS-Mutant Non-Small Cell Lung Cancer (Companion Faculty Lecture)
|
Aug 18, 2022 |
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: KRAS-Mutant Non-Small Cell Lung Cancer
|
Aug 18, 2022 |
Hepatobiliary Cancers | Meet The Professor: Optimizing the Management of Hepatobiliary Cancers — Part 2
|
Aug 17, 2022 |
Gynecologic Cancers | Oncology Today with Dr Neil Love: Advances in Gynecologic Cancers from the 2022 ASCO Annual Meeting (Companion Faculty Lecture)
|
Aug 16, 2022 |
Gynecologic Cancers | Oncology Today with Dr Neil Love: Advances in Gynecologic Cancers from the 2022 ASCO Annual Meeting
|
Aug 16, 2022 |
Gastroesophageal Cancers | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 4
|
Aug 10, 2022 |
Head, Neck and Thyroid Cancers | Key Abstracts in Head, Neck and Thyroid Cancers from the 2022 ASCO Annual Meeting
|
Aug 08, 2022 |
Head, Neck and Thyroid Cancers | Key Abstracts in Head, Neck and Thyroid Cancers from the 2022 ASCO Annual Meeting (Companion Faculty Lecture)
|
Aug 08, 2022 |
Chronic Myeloid Leukemia | Meet The Professor: Optimizing the Management of Chronic Myeloid Leukemia — Part 2
|
Aug 04, 2022 |
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 2
|
Aug 03, 2022 |
Breast Cancer | Oncology Today with Dr Neil Love: Recent Updates in the Management of HER2-Low Breast Cancer
|
Aug 02, 2022 |
Breast Cancer | Oncology Today with Dr Neil Love: Recent Updates in the Management of HER2-Low Breast Cancer (Companion Faculty Lecture)
|
Aug 02, 2022 |
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: Management of Unresectable Stage III Non-Small Cell Lung Cancer
|
Aug 01, 2022 |
Meet The Professor: Optimizing the Management of Hepatobiliary Cancers — Part 1
|
Jul 29, 2022 |
Genitourinary Cancers | Oncology Today with Dr Neil Love: Key Presentations on Genitourinary Cancers from the 2022 ASCO Annual Meeting (Companion faculty lecture)
|
Jul 28, 2022 |
Genitourinary Cancers | Oncology Today with Dr Neil Love: Key Presentations on Genitourinary Cancers from the 2022 ASCO Annual Meeting
|
Jul 28, 2022 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes – A Review of the 2022 ASCO Annual Meeting and EHA Congress
|
Jul 27, 2022 |
Hodgkin and Non-Hodgkin Lymphomas | What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Hodgkin and Non-Hodgkin Lymphomas
|
Jul 22, 2022 |
Cholangiocarcinoma | Oncology Today with Dr Neil Love: Management of Cholangiocarcinoma and Other Biliary Tract Cancers
|
Jul 21, 2022 |
Cholangiocarcinoma | Oncology Today with Dr Neil Love: Management of Cholangiocarcinoma and Other Biliary Tract Cancers (Companion Faculty Lecture)
|
Jul 21, 2022 |
Chronic Myeloid Leukemia | Meet The Professor: Optimizing the Management of Chronic Myeloid Leukemia — Part 1
|
Jul 20, 2022 |
Non-Small Cell Lung Cancer | Meet The Professor: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation — Part 1
|
Jul 19, 2022 |
Breast Cancer | Oncology Today with Dr Neil Love: Key Presentations on Breast Cancer from the 2022 ASCO Annual Meeting (Companion Faculty Lecture)
|
Jul 18, 2022 |
Breast Cancer | Oncology Today with Dr Neil Love: Key Presentations on Breast Cancer from the 2022 ASCO Annual Meeting
|
Jul 18, 2022 |
Chronic Lymphocytic Leukemia | Meet The Professor: Current and Future Management of Chronic Lymphocytic Leukemia — Part 6
|
Jul 15, 2022 |
Prostate Cancer | Fred Saad, MD
|
Jul 14, 2022 |
Prostate Cancer | Johann S de Bono, MB ChB, MSc, PhD, FMedSci
|
Jul 14, 2022 |
Prostate Cancer | PARP Inhibition in the Management of Prostate Cancer — Where We Are and Where We’re Headed
|
Jul 14, 2022 |
Ovarian Cancer | Meet The Professor: Optimizing the Management of Ovarian Cancer — Part 1
|
Jul 13, 2022 |
Non-Small Cell Lung Cancer | Meet The Professor: Non-Small Cell Lung Cancer with an Actionable Target Beyond EGFR — Part 3
|
Jul 12, 2022 |
Multiple Myeloma | Breakfast with the Investigators: Multiple Myeloma
|
Jul 11, 2022 |
Gastroesophageal Cancers | Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 3
|
Jul 08, 2022 |
Breast Cancer | Oncology Today with Dr Neil Love: Recent Updates in HER2-Low Breast Cancer (Companion Faculty Lecture)
|
Jul 07, 2022 |
Breast Cancer | Oncology Today with Dr Neil Love: Recent Updates in HER2-Low Breast Cancer
|
Jul 07, 2022 |
Lung Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jul 06, 2022 |
Hematologic Oncology | Oncology Today with Dr Neil Love: Current and Future Management of Follicular Lymphoma (Companion Video Lecture)
|
Jul 05, 2022 |
Hematologic Oncology | Oncology Today with Dr Neil Love: Current and Future Management of Follicular Lymphoma
|
Jul 05, 2022 |
Urothelial Bladder Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 30, 2022 |
Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma| Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 29, 2022 |
Breast Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 28, 2022 |
Gastrointestinal Cancers| Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 27, 2022 |
Cervical and Endometrial Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
Jun 24, 2022 |
Ovarian Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 23, 2022 |
Prostate Cancer | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 22, 2022 |
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 2
|
Jun 21, 2022 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Proceedings from a CME Hybrid Symposium Series Held in Conjunction with the 2022 ASCO Annual Meeting
|
Jun 20, 2022 |
Gastroesophageal Cancers | What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Gastroesophageal Cancers
|
Jun 17, 2022 |
Myelofibrosis | Meet The Professor: Current and Future Management of Myelofibrosis — Part 3
|
Jun 16, 2022 |
Chronic Lymphocytic Leukemia | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
Jun 14, 2022 |
Urothelial Bladder Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
Jun 13, 2022 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
Jun 10, 2022 |
Chronic Lymphocytic Leukemia | Meet The Professor: Current and Future Management of Chronic Lymphocytic Leukemia — Part 5
|
Jun 09, 2022 |
Small Cell Lung Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
Jun 07, 2022 |
Hepatobiliary Cancers | What I Tell My Patients: Expert Insights into Patient Education on New Treatments and Clinical Trial Participation in Hepatobiliary Cancers
|
Jun 06, 2022 |
Renal Cell Carcinoma | Clinical Investigator Perspectives on the Management of Renal Cell Carcinoma (Faculty Presentation)
|
Jun 02, 2022 |
Renal Cell Carcinoma | Clinical Investigator Perspectives on the Management of Renal Cell Carcinoma
|
Jun 02, 2022 |
Acute Myeloid Leukemia | Striving for Consensus on the Management of Secondary Acute Myeloid Leukemia
|
May 31, 2022 |
Prostate Cancer | Proceedings from a live event held adjunct to the American Urological Association 2022 Annual Meeting
|
May 27, 2022 |
NSCLC | Meet The Professor: Non-Small Cell Lung Cancer with an Actionable Target Beyond EGFR — Part 2
|
May 26, 2022 |
Bladder Cancer | Proceedings from a live event held adjunct to the American Urological Association 2022 Annual Meeting
|
May 25, 2022 |
Ovarian Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
May 24, 2022 |
Meet The Professor: Optimizing the Management of Gastroesophageal Cancers — Part 1
|
May 23, 2022 |
Non-Small Cell Lung Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
May 19, 2022 |
Breast Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
May 17, 2022 |
Prostate Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress
|
May 12, 2022 |
Non-Small Cell Lung Cancer | Meet The Professor: Non-Small Cell Lung Cancer with an Actionable Target Beyond EGFR — Part 1
|
May 06, 2022 |
Hepatobiliary and Pancreatic Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary and Pancreatic Cancers
|
May 05, 2022 |
Ovarian Cancer | Oncology Today with Dr Neil Love: Updates on Ovarian Cancer from SGO 2022
|
May 04, 2022 |
Ovarian Cancer | Oncology Today with Dr Neil Love: Updates on Ovarian Cancer from SGO 2022 (Companion Video Lecture)
|
May 04, 2022 |
Chronic Lymphocytic Leukemia | Meet The Professor: Current and Future Management of Chronic Lymphocytic Leukemia — Part 4
|
Apr 29, 2022 |
Prostate Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Prostate Cancer
|
Apr 27, 2022 |
Myelofibrosis | Meet The Professor: Current and Future Management of Myelofibrosis — Part 2
|
Apr 25, 2022 |
Hodgkin and Non-Hodgkin Lymphomas | Meet The Professor: Optimizing the Clinical Management of Hodgkin and Non-Hodgkin Lymphomas — Part 8
|
Apr 22, 2022 |
Myelodysplastic Syndromes | Meet The Professor: Optimizing the Management of Myelodysplastic Syndromes
|
Apr 21, 2022 |
Breast Cancer | Oncology Today with Dr Neil Love: PARP Inhibitors in Breast Cancer (Companion Video Lecture)
|
Apr 20, 2022 |
Breast Cancer | Oncology Today with Dr Neil Love: PARP Inhibitors in Breast Cancer (Video Interview)
|
Apr 20, 2022 |
Chronic Lymphocytic Leukemia | Meet The Professor: Current and Future Management of Chronic Lymphocytic Leukemia — Part 3
|
Apr 18, 2022 |
Lung Cancer | Meet The Professor: Current and Future Role of Immunotherapy in the Management of Lung Cancer — Part 4
|
Apr 18, 2022 |
Ovarian Cancer | Data + Perspectives: Clinical Investigators Discuss the Current and Future Management of Ovarian Cancer
|
Apr 05, 2022 |
Chronic Lymphocytic Leukemia | Meet The Professor: Current and Future Management of Chronic Lymphocytic Leukemia — Part 2
|
Apr 01, 2022 |
Hodgkin and Non-Hodgkin Lymphomas | Meet The Professor: Optimizing the Clinical Management of Hodgkin and Non-Hodgkin Lymphomas — Part 7
|
Mar 30, 2022 |
Myelofibrosis | Meet The Professor: Current and Future Management of Myelofibrosis — Part 1
|
Mar 28, 2022 |
Acute Myeloid Leukemia| Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia — Part 5
|
Mar 25, 2022 |
Kidney and Bladder Cancer | Elizabeth R Plimack, MD, MS
|
Mar 24, 2022 |
Kidney and Bladder Cancer | Thomas Powles, MBBS, MRCP, MD
|
Mar 24, 2022 |
Kidney and Bladder Cancer | Proceedings From Our Year in Review Webinar on Kidney and Bladder Cancer
|
Mar 24, 2022 |
Lung Cancer | Meet The Professor: Current and Future Role of Immunotherapy in the Management of Lung Cancer — Part 3
|
Mar 23, 2022 |
Chronic Lymphocytic Leukemia | Meet The Professor: Current and Future Management of Chronic Lymphocytic Leukemia — Part 1
|
Mar 21, 2022 |
Prostate Cancer | Meet The Professor: Optimizing the Management of Metastatic Castration-Resistant Prostate Cancer — Part 4
|
Mar 18, 2022 |
Hodgkin and Non-Hodgkin Lymphomas | Meet The Professor: Optimizing the Clinical Management of Hodgkin and Non-Hodgkin Lymphomas — Part 6
|
Mar 17, 2022 |
Breast Cancer | Sara M Tolaney, MD, MPH
|
Mar 16, 2022 |
Lung Cancer | Roy S Herbst, MD, PhD
|
Mar 16, 2022 |
Melanoma | Jeffrey S Weber, MD, PhD
|
Mar 16, 2022 |
Localized Cancer | The Great Adjuvant Debate — Exploring the Role of Novel Therapies in the Management of Localized Cancer
|
Mar 16, 2022 |
Acute Myeloid Leukemia | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia — Part 4
|
Mar 15, 2022 |
Soft Tissue Sarcomas | Oncology Today with Dr Neil Love: Advances in Soft Tissue Sarcomas
|
Mar 14, 2022 |
Multiple Myeloma | Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma from ASH 2021
|
Mar 10, 2022 |
Bladder Cancer | Proceedings From a Live Event Held in Conjunction with the 2022 Genitourinary Cancers Symposium
|
Mar 09, 2022 |
Lung Cancer | Meet The Professor: Current and Future Role of Immunotherapy in the Management of Lung Cancer — Part 2
|
Mar 08, 2022 |
Myeloproliferative Neoplasms | Key Presentations on Advances in Myeloproliferative Neoplasms from ASH 2021
|
Mar 07, 2022 |
Lung Cancer | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 04, 2022 |
Gastrointestinal Cancers | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 04, 2022 |
Breast Cancer | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 04, 2022 |
Multiple Myeloma | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 04, 2022 |
Genitourinary Cancers | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 04, 2022 |
Chronic Lymphocytic Leukemia | Proceedings from a symposium in partnership with NCOA and SCOS
|
Mar 04, 2022 |
Gastric, Gastroesophageal Junction and Esophageal Cancer | David H Ilson, MD, PhD
|
Mar 03, 2022 |
Gastric, Gastroesophageal Junction and Esophageal Cancer | Zev Wainberg, MD, MSc
|
Mar 03, 2022 |
Gastric, Gastroesophageal Junction and Esophageal Cancer | Proceedings From Our Year in Review Webinar on Gastric, Gastroesophageal Junction and Esophageal Cancer
|
Mar 03, 2022 |
Prostate Cancer | Proceedings From a Live Event Held in Conjunction with the 2022 Genitourinary Cancers Symposium
|
Mar 02, 2022 |
Multiple Myeloma | Noopur Raje, MD
|
Mar 01, 2022 |
Multiple Myeloma | Jesús G Berdeja, MD
|
Mar 01, 2022 |
Multiple Myeloma | Proceedings From Our B-Cell Maturation Antigen-Directed Therapy in the Management of Multiple Myeloma Webinar
|
Mar 01, 2022 |
Small-Cell Lung Cancer | Luis Paz-Ares, MD, PhD
|
Feb 28, 2022 |
Small-Cell Lung Cancer | Jared Weiss, MD
|
Feb 28, 2022 |
Small Cell Lung Cancer | Proceedings From Our Small Cell Lung Cancer Webinar
|
Feb 28, 2022 |
Gastroesophageal Cancers | Proceedings from a live event held adjunct to the 2022 Gastrointestinal Cancers Symposium
|
Feb 25, 2022 |
Chronic Lymphocytic Leukemia | Lindsey Roeker, MD
|
Feb 24, 2022 |
Chronic Lymphocytic Leukemia | Jeff Sharman, MD
|
Feb 24, 2022 |
Chronic Lymphocytic Leukemia | Proceedings From Our Year in Review Webinar on Chronic Lymphocytic Leukemia
|
Feb 24, 2022 |
Diffuse Large B-Cell Lymphoma | Grzegorz Nowakowski, MD
|
Feb 23, 2022 |
Diffuse Large B-Cell Lymphoma | Christopher R Flowers, MD, MS
|
Feb 23, 2022 |
Diffuse Large B-Cell Lymphoma | Neha Mehta-Shah, MD, MSCI
|
Feb 23, 2022 |
Diffuse Large B-Cell Lymphoma | Proceedings From Our Diffuse Large B-Cell Lymphoma Webinar
|
Feb 23, 2022 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Gail J Roboz, MD
|
Feb 22, 2022 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Daniel A Pollyea, MD, MS
|
Feb 22, 2022 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Proceedings from our year in review webinar on acute myeloid leukemia and myelodysplastic syndromes
|
Feb 22, 2022 |
Hepatobiliary Cancers | Proceedings from a live event held adjunct to the 2022 Gastrointestinal Cancers Symposium
|
Feb 21, 2022 |
Hodgkin and Non-Hodgkin Lymphomas | Oncology Today with Dr Neil Love: Advances in the Treatment of Hodgkin and Non-Hodgkin Lymphomas from ASH 2021
|
Feb 21, 2022 |
Prostate Cancer | Meet The Professor: Optimizing the Management of Metastatic Castration-Resistant Prostate Cancer — Part 3
|
Feb 18, 2022 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Key Presentations on Acute Myeloid Leukemia and Myelodysplastic Syndromes from ASH 2021
|
Feb 17, 2022 |
Non-Small Cell Lung Cancer | Proceedings From Our Webinar on Promising Investigational Agents and Strategies for Patients with Metastatic Non-Small Cell Lung Cancer Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy
|
Feb 16, 2022 |
Non-Small Cell Lung Cancer | Edward B Garon, MD
|
Feb 16, 2022 |
Breast Cancer | Oncology Today with Dr Neil Love: Current Issues in the Research and Management of Localized Hormone Receptor-Positive Breast Cancer
|
Feb 11, 2022 |
Immunotherapy in Lung Cancer | Proceedings from Our Year in Review Immunotherapy in Lung Cancer Webinar
|
Feb 10, 2022 |
Immunotherapy in Lung Cancer | Anne S Tsao, MD, MBA
|
Feb 10, 2022 |
Immunotherapy in Lung Cancer | Corey J Langer, MD
|
Feb 10, 2022 |
Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Chronic Lymphocytic Leukemia
|
Feb 09, 2022 |
Colorectal Cancer | Proceedings from a live event held adjunct to the 2022 Gastrointestinal Cancers Symposium
|
Feb 08, 2022 |
Breast Cancer | Professor Peter Schmid, FRCP, MD, PhD
|
Feb 07, 2022 |
Breast Cancer | Harold J Burstein, MD, PhD
|
Feb 07, 2022 |
Breast Cancer | Proceedings from Our Year in Review Breast Cancer Webinar
|
Feb 07, 2022 |
Follicular Lymphoma | John P Leonard, MD
|
Feb 05, 2022 |
Follicular Lymphoma | Laurie H Sehn, MD, MPH
|
Feb 05, 2022 |
Follicular Lymphoma | Proceedings from Our Follicular Lymphoma Webinar
|
Feb 05, 2022 |
Prostate Cancer | Meet The Professor: Optimizing the Management of Metastatic Castration-Resistant Prostate Cancer — Part 2
|
Feb 04, 2022 |
Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Updates from the 2021 ASH Meeting on Chronic Lymphocytic Leukemia
|
Feb 03, 2022 |
Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with HER2-Positive Breast Cancer – Part 6
|
Feb 02, 2022 |
Non-Small Cell Lung Cancer | Zofia Piotrowska, MD, MHS
|
Feb 01, 2022 |
Non-Small Cell Lung Cancer | John V Heymach, MD, PhD
|
Feb 01, 2022 |
Non-Small Cell Lung Cancer | Proceedings from Our Targeted Therapy for NSCLC Webinar
|
Feb 01, 2022 |
Multiple Myeloma | Oncology Today with Dr Neil Love: Managing Transplant-Ineligible Newly Diagnosed Multiple Myeloma
|
Jan 31, 2022 |
ER-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with ER-Positive Breast Cancer — Part 4
|
Jan 28, 2022 |
Acute Myeloid Leukemia | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia — Part 3
|
Jan 26, 2022 |
Lymphoma | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Hodgkin and Non-Hodgkin Lymphoma
|
Jan 24, 2022 |
Multiple Myeloma | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma
|
Jan 24, 2022 |
Prostate Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies for the Treatment of Metastatic Castration-Resistant Prostate Cancer
|
Jan 22, 2022 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | What Clinicians Want To Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia and Myelodysplastic Syndromes
|
Jan 22, 2022 |
Lymphoma | Meet The Professor: Optimizing the Clinical Management of Hodgkin and Non-Hodgkin Lymphomas — Part 5
|
Jan 21, 2022 |
Chronic Lymphocytic Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia
|
Jan 19, 2022 |
BRAF-Mutant Melanoma | Meet The Professor: Management of BRAF-Mutant Melanoma — Part 2
|
Jan 18, 2022 |
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Biomarker-Directed Therapy for Colorectal Cancer
|
Jan 15, 2022 |
Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of HER2-Positive Breast Cancer
|
Jan 14, 2022 |
Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of ER-Positive Breast Cancer
|
Jan 14, 2022 |
Acute Myeloid Leukemia | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia — Part 2
|
Jan 13, 2022 |
Pancreatic Cancer | Oncology Today with Dr Neil Love: PARP Inhibition in Pancreatic Cancer
|
Jan 12, 2022 |
Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with HER2-Positive Breast Cancer — Part 5
|
Jan 11, 2022 |
Triple Negative Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Triple-Negative Breast Cancer
|
Jan 08, 2022 |
Lung Cancer | Optimizing Biomarker-Based Decision-Making for Patients with Non-Small Cell Lung Cancer with EGFR Mutations or with Other Oncogene-Addicted Lung Cancers — Session 2
|
Jan 07, 2022 |
Lymphomas | Meet The Professor: Optimizing the Clinical Management of Hodgkin and Non-Hodgkin Lymphomas — Part 4
|
Jan 06, 2022 |
Lung Cancer | Meet The Professor: Current and Future Role of Immunotherapy in the Management of Lung Cancer — Part 1
|
Jan 05, 2022 |
ER-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with ER-Positive Breast Cancer — Part 3
|
Jan 04, 2022 |
Prostate Cancer | Oncology Today with Dr Neil Love: Modern Management of Metastatic Castration-Resistant Prostate Cancer
|
Jan 03, 2022 |
Prostate Cancer | Meet The Professor: Optimizing the Management of Metastatic Castration-Resistant Prostate Cancer — Part 1
|
Dec 29, 2021 |
Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with HER2-Positive Breast Cancer — Part 4
|
Dec 28, 2021 |
Lung Cancer | Key Considerations in the Optimal Clinical Care of Patients with Small Cell Lung Cancer — Session 1
|
Dec 27, 2021 |
Lung Cancer | Key Considerations in the Optimal Clinical Care of Patients with Small Cell Lung Cancer — Session 1 (Faculty Presentations)
|
Dec 27, 2021 |
Urothelial Bladder Carcinoma | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with Urothelial Bladder Carcinoma — Part 2
|
Dec 23, 2021 |
Melanoma | Meet The Professor: Management of BRAF-Mutant Melanoma — Part 1
|
Dec 22, 2021 |
ER-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with ER-Positive Breast Cancer — Part 2
|
Dec 21, 2021 |
Colorectal Cancer | Oncology Today with Dr Neil Love: Advances in Genetic Profiling and Targeted Therapies for Colorectal Cancer
|
Dec 20, 2021 |
Ovarian Cancer | Oncology Today with Dr Neil Love: Ovarian Cancer
|
Dec 17, 2021 |
Lung Cancer | Oncology Today with Dr Neil Love: NSCLC with EGFR Exon 20 Insertion Mutations
|
Dec 17, 2021 |
Lymphomas | Meet The Professor: Optimizing the Clinical Management of Hodgkin and Non-Hodgkin Lymphomas — Part 3
|
Dec 16, 2021 |
Gynecologic Cancer | Oncology Today with Dr Neil Love: Advances in Endometrial Cancer
|
Dec 15, 2021 |
Lung Cancer | Optimizing Biomarker-Based Decision-Making for Patients with Non-Small Cell Lung Cancer with EGFR Mutations or with Other Oncogene-Addicted Lung Cancers
|
Dec 14, 2021 |
Melanoma | Oncology Today with Dr Neil Love: Novel Immunotherapeutic Strategies in Melanoma
|
Dec 13, 2021 |
Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Optimal Management of Hodgkin Lymphoma in Younger and Older Patients
|
Dec 09, 2021 |
Triple-Negative Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with Triple-Negative Breast Cancer — Part 3
|
Dec 08, 2021 |
Non-Hodgkin Lymphoma | Companion virtual lecture series from a live event held during the Society of Hematologic Oncology 2021 Annual Meeting
|
Dec 07, 2021 |
HER2-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with HER2-Positive Breast Cancer — Part 3 of a 6-Part Series
|
Dec 06, 2021 |
ER-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with ER-Positive Breast Cancer — Part 1
|
Dec 02, 2021 |
Bladder Cancer | Proceedings from a live event held adjunct to the American Urological Association’s Annual Meeting
|
Dec 01, 2021 |
Bladder Cancer | Companion virtual lecture series from a live event held adjunct to the American Urological Association’s Annual Meeting
|
Dec 01, 2021 |
Hodgkin and Non-Hodgkin Lymphomas | Fall Oncology Nursing Series: Hodgkin and Non-Hodgkin Lymphomas — Session 3
|
Nov 30, 2021 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Companion virtual lecture series from a live event held during the Society of Hematologic Oncology 2021 Annual Meeting
|
Nov 29, 2021 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Case library from a live event held during the Society of Hematologic Oncology 2021 Annual Meeting
|
Nov 29, 2021 |
CLL and Lymphomas | Fall Oncology Nursing Series: Chimeric Antigen Receptor T-Cell Therapy in Chronic Lymphocytic Leukemia and Lymphomas — Session 2
|
Nov 24, 2021 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists – Part 7: Acute Myeloid Leukemia and Myelodysplastic Syndromes
|
Nov 23, 2021 |
Multiple Myeloma | Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists – Part 6: Multiple Myeloma
|
Nov 23, 2021 |
Chronic Lymphocytic Leukemia and Lymphomas | Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists – Part 5: Chronic Lymphocytic Leukemia and Lymphomas
|
Nov 23, 2021 |
Genitourinary Cancers | Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists – Part 4: Genitourinary Cancers
|
Nov 23, 2021 |
Gastrointestinal Cancers | Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists – Part 3: Gastrointestinal Cancers
|
Nov 23, 2021 |
Lung Cancer | Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists – Part 2: Lung Cancer
|
Nov 23, 2021 |
Breast Cancer | Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists – Part 1: Breast Cancer
|
Nov 23, 2021 |
Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Chronic Lymphocytic Leukemia
|
Nov 22, 2021 |
Acute Myeloid Leukemia | Meet The Professor: Optimizing the Management of Acute Myeloid Leukemia — Part 1
|
Nov 19, 2021 |
Hodgkin and Non-Hodgkin Lymphomas | Meet The Professor: Optimizing the Clinical Management of Hodgkin and Non-Hodgkin Lymphomas — Part 2
|
Nov 18, 2021 |
Triple-Negative Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with Triple-Negative Breast Cancer — Part 2
|
Nov 17, 2021 |
Chronic Lymphocytic Leukemia | Fall Oncology Nursing Series: Chronic Lymphocytic Leukemia — Session 3
|
Nov 16, 2021 |
Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Myelodysplastic Syndromes
|
Nov 15, 2021 |
Gastrointestinal Cancers | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with Advanced Gastrointestinal Cancers — Issue 2
|
Nov 12, 2021 |
Prostate Cancer | Fall Oncology Nursing Series: Prostate Cancer — Session 3
|
Nov 11, 2021 |
Chronic Lymphocytic Leukemia | Companion virtual lecture series from a live event held adjunct to the Society of Hematologic Oncology Annual Meeting
|
Nov 10, 2021 |
Triple-Negative Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with Triple-Negative Breast Cancer — Part 1
|
Nov 09, 2021 |
Non-Hodgkin Lymphoma | Oncology Today with Dr Neil Love: CAR T-Cell Therapy in Non-Hodgkin Lymphoma
|
Nov 08, 2021 |
Head and Neck Cancer | Oncology Today with Dr Neil Love: Head and Neck Cancer
|
Nov 06, 2021 |
Non-Small Cell Lung Cancer | Expert Second Opinion: Investigators Discuss Available Clinical Research in the Care of Patients with Non-Small Cell Lung Cancer and Validated Targets Beyond EGFR
|
Nov 05, 2021 |
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma | Identifying, Managing and Mitigating Therapy-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma (Faculty Presentation)
|
Nov 04, 2021 |
Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma| Identifying, Managing and Mitigating Therapy-Related Adverse Events in Patients with Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
|
Nov 04, 2021 |
Lung Cancer | Exploring the Potential Benefits of Various Adjuvant and Neoadjuvant Therapeutic Approaches for Patients with Localized Non-Small Cell Lung Cancer
|
Nov 02, 2021 |
Myeloproliferative Neoplasms | Oncology Today with Dr Neil Love: Myeloproliferative Neoplasms
|
Nov 01, 2021 |
HER2-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with HER2-Positive Breast Cancer — Part 2
|
Oct 29, 2021 |
Lymphomas | Meet The Professor: Optimizing the Clinical Management of Hodgkin and Non-Hodgkin Lymphomas — Part 1
|
Oct 28, 2021 |
Urothelial Bladder Carcinoma | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with Urothelial Bladder Carcinoma
|
Oct 27, 2021 |
Chronic Myeloid Leukemia | Oncology Today with Dr Neil Love: Chronic Myeloid Leukemia
|
Oct 26, 2021 |
Non-Hodgkin Lymphoma | Proceedings from a live event held during the Society of Hematologic Oncology 2021 Annual Meeting
|
Oct 23, 2021 |
Lymphomas | Fall Oncology Nursing Series: Hodgkin and Non-Hodgkin Lymphomas — Session 2
|
Oct 22, 2021 |
Multiple Myeloma | Proceedings from a live event held in conjunction with the 2021 Pan Pacific Lymphoma Conference
|
Oct 21, 2021 |
Chronic Lymphocytic Leukemia | Proceedings from a live event held during the Society of Hematologic Oncology 2021 Annual Meeting
|
Oct 21, 2021 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Proceedings from a live event held during the Society of Hematologic Oncology 2021 Annual Meeting
|
Oct 20, 2021 |
Prostate Cancer | Proceedings from a live event held adjunct to the American Urological Association’s Annual Meeting
|
Oct 15, 2021 |
Lung Cancer | Expert Second Opinion: The Emerging Role of Immunotherapy and Targeted Treatment in Localized Non-Small Cell Lung Cancer
|
Oct 14, 2021 |
Breast Cancer | Fall Oncology Nursing Series: Breast Cancer — Session 3
|
Oct 13, 2021 |
Gynecologic Cancer | Summer Oncology Nursing Series: Gynecologic Cancer — Session 2
|
Oct 11, 2021 |
Acute Myeloid Leukemia | Proceedings from a live event held in conjunction with the 2021 Pan Pacific Lymphoma Conference
|
Oct 08, 2021 |
Renal Cell Carcinoma | Oncology Today with Dr Neil Love: Renal Cell Carcinoma
|
Oct 08, 2021 |
Colorectal Cancer | Companion virtual lecture from a live event exploring key issues affecting the care of patients with metastatic colorectal cancer with BRAF mutations
|
Oct 07, 2021 |
Colorectal Cancer | Proceedings from a live event exploring key issues affecting the care of patients with metastatic colorectal cancer with BRAF mutations
|
Oct 07, 2021 |
Prostate Cancer | Summer Oncology Nursing Series: Prostate Cancer — Session 2
|
Oct 06, 2021 |
Thyroid Cancer | Oncology Today with Dr Neil Love: Thyroid Cancer — Issue 2
|
Oct 04, 2021 |
Chronic Lymphocytic Leukemia | Summer Oncology Nursing Series: Chronic Lymphocytic Leukemia — Session 2
|
Oct 01, 2021 |
Gastroesophageal Cancers | Oncology Today with Dr Neil Love: Gastroesophageal Cancers — Issue 2
|
Sep 30, 2021 |
Renal Cell Carcinoma | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with Renal Cell Carcinoma
|
Sep 29, 2021 |
Chronic Lymphocytic Leukemia | Proceedings from a live event held in conjunction with the 2021 Pan Pacific Lymphoma Conference
|
Sep 28, 2021 |
Hepatocellular Carcinoma and Pancreatic Cancer | Eileen M O’Reilly, MD
|
Sep 27, 2021 |
Hepatocellular Carcinoma and Pancreatic Cancer | Tanios Bekaii-Saab, MD
|
Sep 27, 2021 |
Hepatocellular Carcinoma and Pancreatic Cancer | Kim A Reiss Binder, MD
|
Sep 27, 2021 |
Hepatocellular Carcinoma and Pancreatic Cancer | Philip A Philip, MD, PhD, FRCP
|
Sep 27, 2021 |
Hepatocellular Carcinoma and Pancreatic Cancer | Proceedings from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Sep 27, 2021 |
Breast Cancer | Oncology Today with Dr Neil Love: Management of HER2-Low Breast Cancer
|
Sep 23, 2021 |
Breast Cancer | Summer Oncology Nursing Series: Breast Cancer — Session 2
|
Sep 20, 2021 |
Gynecologic Oncology | Summer Oncology Nursing Series: Gynecologic Cancer — Session 1
|
Sep 17, 2021 |
Head and Neck Cancer | Proceedings from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Sep 16, 2021 |
HER2-Positive Breast Cancer | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with HER2-Positive Breast Cancer — Part 1 of a 5-Part Series
|
Sep 14, 2021 |
Non-Small Cell Lung Cancer | Summer Oncology Nursing Series: Non-Small Cell Lung Cancer
|
Sep 11, 2021 |
Mantle Cell, Diffuse Large B-Cell and Hodgkin Lymphoma | Companion virtual lecture series from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Sep 10, 2021 |
Mantle Cell, Diffuse Large B-Cell and Hodgkin Lymphoma | Proceedings from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Sep 10, 2021 |
Endometrial and Cervical Cancers | Companion virtual lecture series from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Sep 09, 2021 |
Endometrial and Cervical Cancers | Proceedings from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Sep 09, 2021 |
Immunotherapy and Other Nontargeted Approaches for Lung Cancer | Companion virtual lecture series from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Sep 08, 2021 |
Immunotherapy and Other Nontargeted Approaches for Lung Cancer | Proceedings from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Sep 08, 2021 |
Colorectal and Gastroesophageal Cancers | Companion virtual lecture series from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Sep 07, 2021 |
Colorectal and Gastroesophageal Cancers | Proceedings from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Sep 07, 2021 |
Prostate Cancer | Summer Oncology Nursing Series: Prostate Cancer — Session 1
|
Sep 03, 2021 |
Gynecologic Cancers | Oncology Today with Dr Neil Love: Key Presentations on Gynecologic Cancers from the 2021 ASCO Annual Meeting
|
Sep 02, 2021 |
Targeted Non-Small Cell Lung Cancer | Companion virtual lecture series from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Sep 01, 2021 |
Targeted Non-Small Cell Lung Cancer | Proceedings from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Sep 01, 2021 |
Bladder Cancer | Companion virtual lecture series from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Aug 31, 2021 |
Bladder Cancer | Proceedings from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Aug 31, 2021 |
Metastatic Castration-Resistant Prostate Cancer | Companion virtual lecture series from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Aug 30, 2021 |
Metastatic Castration-Resistant Prostate Cancer | Proceedings from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Aug 30, 2021 |
Multiple Myeloma | Summer Oncology Nursing Series: Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma — Session 1
|
Aug 28, 2021 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Proceedings from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Aug 27, 2021 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Companion virtual lecture series from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Aug 27, 2021 |
CAR-T Cell Therapy | Proceedings from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Aug 25, 2021 |
CAR-T Cell Therapy | Companion virtual lecture series from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Aug 25, 2021 |
Chronic Lymphocytic Leukemia | Visiting The Investigators: Prevention and Management of Tumor Lysis Syndrome, Neutropenia and Other Toxicities Associated with Novel Therapies for Chronic Lymphocytic Leukemia
|
Aug 24, 2021 |
Thyroid Cancer | Oncology Today with Dr Neil Love: Thyroid Cancer — Issue 1
|
Aug 19, 2021 |
Gastrointestinal Cancers | Meet The Professor: Optimizing the Selection and Sequencing of Therapy for Patients with Advanced Gastrointestinal Cancers — Issue 1
|
Aug 18, 2021 |
Lung Cancer | Oncology Today with Dr Neil Love: Key Presentations on Lung Cancer from the 2021 ASCO Annual Meeting
|
Aug 16, 2021 |
Renal Cell Carcinoma | Proceedings from a live event held in partnership with Project ECHO® and Florida Cancer Specialists
|
Aug 13, 2021 |
Ovarian Cancer | Companion virtual lecture series from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Aug 12, 2021 |
Ovarian Cancer | Proceedings from a live event held adjunct to the 2021 ASCO Annual Meeting
|
Aug 12, 2021 |
Multiple Myeloma | Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Multiple Myeloma
|
Aug 10, 2021 |
Multiple Myeloma | Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Multiple Myeloma (Faculty Presentations)
|
Aug 10, 2021 |
Prostate Cancer | A Conversation with the Investigators: Hormonal Therapy for Prostate Cancer (Faculty Presentations)
|
Aug 06, 2021 |
Prostate Cancer | A Conversation with the Investigators: Hormonal Therapy for Prostate Cancer
|
Aug 06, 2021 |
Multiple Myeloma | Oncology Today with Dr Neil Love: CAR T-Cell Therapy in Multiple Myeloma
|
Aug 05, 2021 |
Hodgkin and Non-Hodgkin Lymphomas | Summer Oncology Nursing Series: Hodgkin and Non-Hodgkin Lymphomas — Session 1
|
Aug 03, 2021 |
Chronic Lymphocytic Leukemia and Follicular Lymphoma | Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Chronic Lymphocytic Leukemia and Follicular Lymphoma (Faculty Presentations)
|
Aug 02, 2021 |
Chronic Lymphocytic Leukemia and Follicular Lymphoma | Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Chronic Lymphocytic Leukemia and Follicular Lymphoma
|
Aug 02, 2021 |
Gastrointestinal Cancers | Oncology Today with Dr Neil Love: Key Presentations on Gastrointestinal Cancers from the 2021 ASCO Annual Meeting
|
Jul 31, 2021 |
Breast Cancer | Oncology Today with Dr Neil Love: Key Presentations on Breast Cancer from the 2021 ASCO Annual Meeting
|
Jul 23, 2021 |
Gastroesophageal Cancers | Oncology Today with Dr Neil Love: Gastroesophageal Cancers
|
Jul 22, 2021 |
Breast Cancer | ASCO Highlights and More: Investigators Review Recent Data Sets and Provide Perspectives on Current Oncology Care Part 6: Breast Cancer
|
Jul 20, 2021 |
Gynecologic Cancers | ASCO Highlights and More: Investigators Review Recent Data Sets and Provide Perspectives on Current Oncology Care Part 5: Gynecologic Cancers
|
Jul 20, 2021 |
Gastrointestinal Cancers | ASCO Highlights and More: Investigators Review Recent Data Sets and Provide Perspectives on Current Oncology Care Part 4: Gastrointestinal Cancers
|
Jul 20, 2021 |
Chronic Lymphocytic Leukemia and Lymphomas | ASCO Highlights and More: Investigators Review Recent Data Sets and Provide Perspectives on Current Oncology Care Part 3: Chronic Lymphocytic Leukemia and Lymphomas
|
Jul 20, 2021 |
Genitourinary Cancers | ASCO Highlights and More: Investigators Review Recent Data Sets and Provide Perspectives on Current Oncology Care Part 2: Genitourinary Cancers
|
Jul 20, 2021 |
Lung Cancer | ASCO Highlights and More: Investigators Review Recent Data Sets and Provide Perspectives on Current Oncology Care Part 1: Lung Cancer
|
Jul 20, 2021 |
ER-Positive and Triple-Negative Breast Cancer | Expert Second Opinion: Investigators Discuss Available Clinical Research in the Care of Patients with Challenging Cases of ER-Positive and Triple-Negative Breast Cancer (Faculty Presentations)
|
Jul 17, 2021 |
ER-Positive and Triple-Negative Breast Cancer | Expert Second Opinion: Investigators Discuss Available Clinical Research in the Care of Patients with Challenging Cases of ER-Positive and Triple-Negative Breast Cancer
|
Jul 16, 2021 |
Genitourinary Cancers | Oncology Today with Dr Neil Love: Key Presentations on Genitourinary Cancers from the 2021 ASCO Annual Meeting
|
Jul 15, 2021 |
Myelodysplastic Syndromes | Oncology Today with Dr Neil Love: Progress in Myelodysplastic Syndromes
|
Jul 14, 2021 |
HER2-Positive Breast Cancer | Expert Second Opinion: Investigators Discuss Available Clinical Research in the Care of Patients with Challenging Cases of HER2-Positive Breast Cancer
|
Jul 09, 2021 |
HER2-Positive Breast Cancer | Expert Second Opinion: Investigators Discuss Available Clinical Research in the Care of Patients with Challenging Cases of HER2-Positive Breast Cancer (Faculty Presentations)
|
Jul 09, 2021 |
Chronic Lymphocytic Leukemia | Summer Oncology Nursing Series: Chronic Lymphocytic Leukemia — Session 1
|
Jun 30, 2021 |
Breast Cancer | Summer Oncology Nursing Series: Breast Cancer — Session 1
|
Jun 28, 2021 |
Breast Cancer | Up for Debate: Oncology Investigators Provide Their Take on Current Controversies in Patient Care Part 5: Breast Cancer
|
Jun 19, 2021 |
Multiple Myeloma | Up for Debate: Oncology Investigators Provide Their Take on Current Controversies in Patient Care Part 4: Multiple Myeloma
|
Jun 18, 2021 |
Chronic Lymphocytic Leukemia | Up for Debate: Oncology Investigators Provide Their Take on Current Controversies in Patient Care Part 3: Chronic Lymphocytic Leukemia
|
Jun 18, 2021 |
Genitourinary Cancers | Up for Debate: Oncology Investigators Provide Their Take on Current Controversies in Patient Care Part 2: Genitourinary Cancers
|
Jun 18, 2021 |
Lung Cancer | Up for Debate: Oncology Investigators Provide Their Take on Current Controversies in Patient Care Part 1: Lung Cancer
|
Jun 18, 2021 |
Acute Myeloid Leukemia | Bringing the Patient into the Equation: A Pilot CME Initiative on the Treatment of Acute Myeloid Leukemia — Issue 2
|
Jun 17, 2021 |
Hematologic Oncology | Exploring Clinical Investigator Perspectives on the Optimal Management of Multiple Myeloma
|
Jun 15, 2021 |
Lung Cancer | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 7: Lung Cancer
|
Jun 12, 2021 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 6: Acute Myeloid Leukemia and Myelodysplastic Syndromes
|
Jun 12, 2021 |
Gastrointestinal Cancers | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 5: Gastrointestinal Cancers
|
Jun 11, 2021 |
Genitourinary Cancers | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 4: Genitourinary Cancers
|
Jun 11, 2021 |
Chronic Lymphocytic Leukemia and Lymphomas | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 3: Chronic Lymphocytic Leukemia and Lymphomas
|
Jun 11, 2021 |
Multiple Myeloma | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 2: Multiple Myeloma
|
Jun 11, 2021 |
Breast Cancer | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 1: Breast Cancer
|
Jun 11, 2021 |
Chronic Lymphocytic Leukemia | Meet The Professors: Management of Chronic Lymphocytic Leukemia
|
Jun 10, 2021 |
Multiple Myeloma | Oncology Grand Rounds Series: Part 7 — Multiple Myeloma
|
Jun 08, 2021 |
Colorectal and Gastroesophageal Cancers | Oncology Grand Rounds Series: Part 4 — Colorectal and Gastroesophageal Cancers
|
Jun 07, 2021 |
Acute Myeloid Leukemia | Oncology Grand Rounds Series: Part 3 — Acute Myeloid Leukemia
|
Jun 07, 2021 |
Urothelial Bladder Carcinoma | Oncology Grand Rounds Series: Part 9 — Urothelial Bladder Carcinoma
|
Jun 04, 2021 |
Chimeric Antigen Receptor T-Cell Therapy | Oncology Grand Rounds Series: Part 11 — Chimeric Antigen Receptor T-Cell Therapy
|
Jun 03, 2021 |
Prostate Cancer | Oncology Grand Rounds Series: Part 5 — Prostate Cancer
|
Jun 03, 2021 |
Gynecologic Cancers | Oncology Grand Rounds Series: Part 8 — Gynecologic Cancers
|
Jun 02, 2021 |
Lung Cancer | Meet The Professors: Management of Lung Cancer
|
Jun 02, 2021 |
Chronic Lymphocytic Leukemia | Exploring Clinical Investigator Perspectives on the Optimal Management of Chronic Lymphocytic Leukemia (for Hematology-Oncology Fellows)
|
May 28, 2021 |
Non-Small Cell Lung Cancer | Oncology Grand Rounds Series: Part 2 — Non-Small Cell Lung Cancer
|
May 27, 2021 |
Hodgkin and Non-Hodgkin Lymphomas | Oncology Grand Rounds Series: Part 6 — Hodgkin and Non-Hodgkin Lymphomas
|
May 27, 2021 |
Chronic Lymphocytic Leukemia | Oncology Grand Rounds Series: Part 10 — Chronic Lymphocytic Leukemia
|
May 26, 2021 |
Breast Cancer | Oncology Grand Rounds Series: Part 1 — Breast Cancer
|
May 20, 2021 |
HER2-Positive Localized Breast Cancer | Oncology Today with Dr Neil Love: HER2-Positive Localized Breast Cancer
|
May 19, 2021 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 7: Acute Myeloid Leukemia and Myelodysplastic Syndromes
|
May 19, 2021 |
Breast Cancer | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 6: Breast Cancer
|
May 19, 2021 |
Gastrointestinal Cancers | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 5: Gastrointestinal Cancers
|
May 19, 2021 |
Lung Cancer | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 4: Lung Cancer
|
May 19, 2021 |
Genitourinary Cancers | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 3: Genitourinary Cancers
|
May 19, 2021 |
Multiple Myeloma | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 2: Multiple Myeloma
|
May 18, 2021 |
Chronic Lymphocytic Leukemia and Lymphomas | Real World Oncology Rounds: Current Concepts and Recent Advances in Oncology Part 1: Chronic Lymphocytic Leukemia and Lymphomas
|
May 18, 2021 |
Lung Cancer | Exploring the Multidisciplinary Management of Localized Non-Small Cell Lung Cancer with EGFR Mutation
|
May 17, 2021 |
HER2-Positive Breast Cancer | Dissecting the Decision: Clinical and Nursing Investigators Provide Practical Perspectives on Key Issues in HER2-Positive Breast Cancer
|
May 15, 2021 |
Ovarian Cancer | Cases from the Community: Investigators Discuss the Role of PARP Inhibition in the Care of Actual Patients with Ovarian Cancer (Faculty Presentations)
|
May 13, 2021 |
Ovarian Cancer | Cases from the Community: Investigators Discuss the Role of PARP Inhibition in the Care of Actual Patients with Ovarian Cancer
|
May 13, 2021 |
Breast Cancer | Oncology Today with Dr Neil Love: Genomic Assays in Early Breast Cancer
|
May 12, 2021 |
Gastroesophageal Cancers | Ask the Investigators: Applying Emerging Clinical Research to the Care of Patients with Gastroesophageal Cancers
|
May 08, 2021 |
Acute Myeloid Leukemia | Data + Perspectives: Investigators Discuss the Effects of Emerging Research on the Care of Patients with Acute Myeloid Leukemia
|
May 06, 2021 |
Triple-Negative Breast Cancer | Cancer Conference Update: What Happened at the 2020 San Antonio Breast Cancer Symposium® — Triple-Negative Breast Cancer (Session 2)
|
May 05, 2021 |
HER2-Positive Breast Cancer | Cancer Conference Update: What Happened at the 2020 San Antonio Breast Cancer Symposium® — HER2-Positive Breast Cancer (Session 2)
|
May 04, 2021 |
Acute Myeloid Leukemia | Dissecting the Decision: Clinical and Nursing Investigators Provide Practical Perspectives on Key Issues in Acute Myeloid Leukemia
|
May 03, 2021 |
Amyloid Light Chain Amyloidosis | Oncology Today with Dr Neil Love: Advances in the Management of Amyloid Light Chain Amyloidosis
|
May 01, 2021 |
Cholangiocarcinoma | Oncology Today with Dr Neil Love: Advances in the Management of Cholangiocarcinoma
|
Apr 29, 2021 |
Renal Cell Carcinoma | Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Renal Cell Carcinoma (Faculty Presentations)
|
Apr 28, 2021 |
Renal Cell Carcinoma | Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Renal Cell Carcinoma
|
Apr 28, 2021 |
Acute Myeloid Leukemia | Bringing The Patient into the Equation: A Pilot CME Initiative on the Treatment of Acute Myeloid Leukemia — Issue 1
|
Apr 27, 2021 |
Prostate Cancer | Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Prostate Cancer (Faculty Presentations)
|
Apr 24, 2021 |
Prostate Cancer | Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Prostate Cancer
|
Apr 24, 2021 |
Chronic Lymphocytic Leukemia | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Chronic Lymphocytic Leukemia (Faculty Presentations)
|
Apr 22, 2021 |
Chronic Lymphocytic Leukemia | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Chronic Lymphocytic Leukemia
|
Apr 22, 2021 |
Chronic Lymphocytic Leukemia | Recent Advances in Hematologic Oncology: A 4-Part Live Webinar Series Reviewing Key Data and Presentations from the 62nd ASH Annual Meeting — Chronic Lymphocytic Leukemia (Part 4)
|
Apr 21, 2021 |
Urothelial Bladder Carcinoma | Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Urothelial Bladder Carcinoma (Faculty Presentations)
|
Apr 20, 2021 |
Urothelial Bladder Carcinoma | Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Urothelial Bladder Carcinoma
|
Apr 20, 2021 |
Multiple Myeloma | Recent Advances in Hematologic Oncology: A 4-Part Live Webinar Series Reviewing Key Data and Presentations from the 62nd ASH Annual Meeting — Multiple Myeloma (Part 3)
|
Apr 19, 2021 |
Hodgkin and Non-Hodgkin Lymphoma | Recent Advances in Hematologic Oncology: A 4-Part Live Webinar Series Reviewing Key Data and Presentations from the 62nd ASH Annual Meeting — Hodgkin and Non-Hodgkin Lymphoma (Part 2)
|
Apr 18, 2021 |
Lung Cancer | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Targeted Therapy for Lung Cancer (Faculty Presentations)
|
Apr 17, 2021 |
Lung Cancer | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Targeted Therapy for Lung Cancer
|
Apr 17, 2021 |
Multiple Myeloma | Meet The Professors: Management of Multiple Myeloma
|
Apr 16, 2021 |
Acute Myeloid Leukemia | Recent Advances in Hematologic Oncology: A 4-Part Live Webinar Series Reviewing Key Data and Presentations from the 62nd ASH Annual Meeting — Acute Myeloid Leukemia (Part 1)
|
Apr 15, 2021 |
Breast Cancer | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Breast Cancer (Faculty Presentations)
|
Apr 13, 2021 |
Breast Cancer | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Breast Cancer
|
Apr 13, 2021 |
Lung Cancer | Oncology Today with Dr Neil Love: Management of Localized Non-Small Cell Lung Cancer with EGFR Tumor Mutations
|
Apr 12, 2021 |
Ovarian Cancer | What Clinicians Want to Know: Understanding the Factors Affecting the Optimal Diagnosis and Management of Ovarian Cancer
|
Apr 10, 2021 |
Colorectal Cancer | Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Colorectal Cancer (Faculty Presentations)
|
Apr 09, 2021 |
Colorectal Cancer | Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Colorectal Cancer
|
Apr 08, 2021 |
Hematologic Oncology | Oncology Today with Dr Neil Love: Key Presentations on Non-Hodgkin and Hodgkin Lymphomas from the 2020 ASH Annual Meeting — Issue 2
|
Apr 07, 2021 |
HER2-Positive Breast Cancer | Striving for Consensus on the Optimal Management of HER2-Positive Breast Cancer
|
Apr 06, 2021 |
Hematologic Oncology | Oncology Today with Dr Neil Love: Key Presentations on Multiple Myeloma, Waldenström Macroglobulinemia and Amyloidosis from the 2020 ASH Annual Meeting
|
Apr 05, 2021 |
HER2-Positive Breast Cancer | Cancer Conference Update: What Happened at the 2020 San Antonio Breast Cancer Symposium® — HER2-Positive Breast Cancer (Session 1)
|
Apr 03, 2021 |
Triple-Negative Breast Cancer | Cancer Conference Update: What Happened at the 2020 San Antonio Breast Cancer Symposium® — Triple-Negative Breast Cancer (Session 1)
|
Apr 02, 2021 |
Genitourinary Cancers | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Bladder Cancer and Renal Cell Carcinoma (Faculty Presentations)
|
Apr 01, 2021 |
Genitourinary Cancers | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Bladder Cancer and Renal Cell Carcinoma
|
Apr 01, 2021 |
Multiple Myeloma | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Multiple Myeloma (Faculty Presentations)
|
Mar 31, 2021 |
Multiple Myeloma | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Multiple Myeloma
|
Mar 31, 2021 |
Prostate Cancer | Oncology Today with Dr Neil Love: Side Effects of Hormonal Therapy in Prostate Cancer
|
Mar 30, 2021 |
Hematologic Oncology | Oncology Today with Dr Neil Love: Key Presentations on Acute Myeloid Leukemia and Myelodysplastic Syndromes from the 2020 ASH Annual Meeting
|
Mar 26, 2021 |
Gynecologic Cancers | Meet The Professor: Immunotherapy and Novel Agents in Gynecologic Cancers
|
Mar 26, 2021 |
Gastrointestinal Cancers | Yelena Y Janjigian, MD
|
Mar 25, 2021 |
Gastrointestinal Cancers | Daniel Catenacci, MD
|
Mar 25, 2021 |
Gastrointestinal Cancers | Rutika Mehta, MD, MPH
|
Mar 25, 2021 |
Gastrointestinal Cancers | Zev Wainberg, MD, MSc
|
Mar 25, 2021 |
Gastrointestinal Cancers | Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Gastroesophageal Cancers
|
Mar 25, 2021 |
Lung Cancer | Oncology Today with Dr Neil Love: Management of CNS Metastases in Patients with Non-Small Cell Lung Cancer
|
Mar 24, 2021 |
Prostate Cancer | Charles J Ryan, MD
|
Mar 23, 2021 |
Prostate Cancer | Johann de Bono, MBChB, MSc, PhD
|
Mar 23, 2021 |
Hematologic Oncology | Oncology Today with Dr Neil Love: Novel and Emerging Strategies for Diffuse Large B-Cell Lymphoma
|
Mar 22, 2021 |
Lung Cancer | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Nontargeted Therapy for Lung Cancer (Faculty Presentations)
|
Mar 20, 2021 |
Lung Cancer | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Nontargeted Therapy for Lung Cancer
|
Mar 20, 2021 |
Acute Myeloid Leukemia | Oncology Today with Dr Neil Love: Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy
|
Mar 19, 2021 |
Ovarian Cancer | Oncology Today with Dr Neil Love: PARP Inhibitors in Ovarian Cancer
|
Mar 16, 2021 |
Lymphomas | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Lymphoma (Faculty Presentations)
|
Mar 13, 2021 |
Lymphomas | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Lymphomas
|
Mar 13, 2021 |
Lung Cancer | Oncology Today with Dr Neil Love: Predictors of Response to Cancer Immunotherapy
|
Mar 12, 2021 |
Hepatocellular Carcinoma | Ahmed Omar Kaseb, MD, CMQ
|
Mar 12, 2021 |
Hepatocellular Carcinoma | Tim Greten, MD
|
Mar 12, 2021 |
Hepatocellular Carcinoma | James J Harding, MD
|
Mar 12, 2021 |
Hepatocellular Carcinoma | Richard S Finn, MD
|
Mar 12, 2021 |
Hepatocellular Carcinoma | Cases from the Community: Investigators Discuss Emerging Research and Actual Patients with Hepatocellular Carcinoma
|
Mar 11, 2021 |
Multiple Myeloma | Oncology Today with Dr Neil Love: Recently Approved Agents in Multiple Myeloma
|
Mar 10, 2021 |
Lung Cancer | Oncology Today with Dr Neil Love: Current and Emerging Strategies for Patients with Non-Small Cell Lung Cancer Harboring an EGFR Exon 20 Insertion Mutation
|
Mar 08, 2021 |
Chronic Lymphocytic Leukemia | Paul M Barr, MD
|
Mar 06, 2021 |
Chronic Lymphocytic Leukemia | Stephan Stilgenbauer, MD
|
Mar 06, 2021 |
Chronic Lymphocytic Leukemia | Matthew S Davids, MD, MMSc
|
Mar 06, 2021 |
Chronic Lymphocytic Leukemia | Kerry Rogers, MD
|
Mar 06, 2021 |
Chronic Lymphocytic Leukemia | Tanya Siddiqi, MD
|
Mar 06, 2021 |
Breast Cancer | Oncology Today with Dr Neil Love: Newly Approved Agents in HER2-Positive Metastatic Breast Cancer
|
Mar 05, 2021 |
Endometrial Cancer | Practical Considerations Surrounding the Use of Immune Checkpoint Inhibitors in the Management of Endometrial Cancer
|
Mar 04, 2021 |
Gynecologic Cancers | Robert L Coleman, MD
|
Feb 27, 2021 |
Gynecologic Cancers | Richard T Penson, MD, MRCP
|
Feb 27, 2021 |
Gynecologic Cancers | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Gynecologic Cancers
|
Feb 27, 2021 |
Lung Cancer | Oncology Today with Dr Neil Love: New Targets in Non-Small Cell Lung Cancer
|
Feb 26, 2021 |
Chronic Lymphocytic Leukemia | Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Chronic Lymphocytic Leukemia
|
Feb 25, 2021 |
Breast Cancer | Oncology Today with Dr Neil Love: ER-Positive Metastatic Breast Cancer
|
Feb 24, 2021 |
Ovarian Cancer | Oncology Today with Dr Neil Love: Current and Future Treatment Strategies for Advanced Ovarian Cancer
|
Feb 22, 2021 |
Multiple Myeloma | Rafael Fonseca, MD
|
Feb 20, 2021 |
Multiple Myeloma | Ola Landgren, MD, PhD
|
Feb 20, 2021 |
Multiple Myeloma | Nikhil C Munshi, MD
|
Feb 20, 2021 |
Multiple Myeloma | Robert Z Orlowski, MD, PhD
|
Feb 20, 2021 |
Multiple Myeloma | Edward A Stadtmauer, MD
|
Feb 20, 2021 |
Multiple Myeloma | Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Multiple Myeloma
|
Feb 20, 2021 |
Chronic Lymphocytic Leukemia and Follicular Lymphoma | Oncology Today with Dr Neil Love: Key Presentations on Chronic Lymphocytic Leukemia and Follicular Lymphoma from the 2020 ASH Annual Meeting — Issue 1
|
Feb 19, 2021 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|
Feb 19, 2021 |
Acute Myeloid Leukemia and Myelodysplastic Syndromes | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Acute Myeloid Leukemia and Myelodysplastic Syndromes
|
Feb 18, 2021 |
Ovarian Cancer | Meet The Professor: Management of Ovarian Cancer
|
Feb 17, 2021 |
Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Front-Line Treatment of Chronic Lymphocytic Leukemia — Issue 2
|
Feb 16, 2021 |
HER2-Positive Breast Cancer | Carey K Anders, MD
|
Feb 15, 2021 |
HER2-Positive Breast Cancer | Erika Hamilton, MD
|
Feb 15, 2021 |
HER2-Positive Breast Cancer | Sara Hurvitz, MD
|
Feb 15, 2021 |
HER2-Positive Breast Cancer | Mark D Pegram, MD
|
Feb 15, 2021 |
HER2-Positive Breast Cancer | Sara M Tolaney, MD, MPH
|
Feb 15, 2021 |
Hematologic Oncology | Oncology Today with Dr Neil Love: Key Presentations on Myeloproliferative Neoplasms from the 2020 ASH Annual Meeting
|
Feb 12, 2021 |
Hodgkin and Non-Hodgkin Lymphoma | Jonathan W Friedberg, MD, MMSc
|
Feb 11, 2021 |
Hodgkin and Non-Hodgkin Lymphoma | Ann S LaCasce, MD, MMSc
|
Feb 11, 2021 |
Hodgkin and Non-Hodgkin Lymphoma | John P Leonard, MD
|
Feb 11, 2021 |
Hodgkin and Non-Hodgkin Lymphoma | Michael E Williams, MD, ScM
|
Feb 11, 2021 |
Hodgkin and Non-Hodgkin Lymphoma | John Kuruvilla, MD
|
Feb 11, 2021 |
Hodgkin and Non-Hodgkin Lymphoma | Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Hodgkin and Non-Hodgkin Lymphoma
|
Feb 11, 2021 |
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Newly Approved Agents in the Management of Urothelial Bladder Carcinoma
|
Feb 10, 2021 |
HER2-Positive Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of HER2-Positive Breast Cancer
|
Feb 09, 2021 |
Prostate Cancer | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Prostate Cancer
|
Feb 09, 2021 |
Prostate Cancer | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Prostate Cancer
|
Feb 08, 2021 |
Melanoma | Michael A Davies, MD, PhD
|
Feb 05, 2021 |
Melanoma | Karl D Lewis, MD
|
Feb 05, 2021 |
Acute Myeloid Leukemia | Andrew H Wei, MBBS, PhD
|
Feb 04, 2021 |
Acute Myeloid Leukemia | Alexander Perl, MD
|
Feb 04, 2021 |
Acute Myeloid Leukemia | Eytan M Stein, MD
|
Feb 04, 2021 |
Acute Myeloid Leukemia | Mark Levis, MD, PhD
|
Feb 04, 2021 |
Acute Myeloid Leukemia | Daniel A Pollyea, MD, MS
|
Feb 04, 2021 |
Acute Myeloid Leukemia | Consensus or Controversy? Investigators Discuss Clinical Practice Patterns and Available Research Data Guiding the Management of Acute Myeloid Leukemia
|
Feb 04, 2021 |
Gastrointestinal Cancers | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Colorectal and Gastroesophageal Cancers (Faculty Presentations)
|
Feb 03, 2021 |
Gastrointestinal Cancers | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Colorectal and Gastroesophageal Cancers
|
Feb 02, 2021 |
Lung Cancer | Optimizing the Role of Radiation Oncologists and Other Multidisciplinary Team Members in the Management of Locally Advanced Non-Small Cell Lung Cancer (Faculty Presentations)
|
Feb 02, 2021 |
Prostate Cancer | Fred Saad, MD
|
Feb 01, 2021 |
Prostate Cancer | Philip Kantoff, MD
|
Feb 01, 2021 |
Lung Cancer | Oncology Today with Dr Neil Love: Role of Immune Checkpoint Inhibitors in the Management of Metastatic NSCLC without Actionable Mutations
|
Jan 29, 2021 |
Hepatocellular Carcinoma | Lipika Goyal, MD, MPhil
|
Jan 28, 2021 |
Pancreaticobiliary Cancers | Tanios Bekaii-Saab, MD
|
Jan 28, 2021 |
Gastrointestinal Cancers | Year in Review: Clinical Investigators Provide Perspectives on the Most Relevant New Publications, Data Sets and Advances in Hepatobiliary and Pancreatic Cancers
|
Jan 27, 2021 |
Urothelial Bladder Carcinoma | Newly Approved Agents for Patients with Metastatic Urothelial Bladder Carcinoma Who Experience Disease Progression on Immune Checkpoint Inhibitor Therapy
|
Jan 26, 2021 |
Triple-Negative Breast Cancer | Professor Peter Schmid, MD, PhD
|
Jan 26, 2021 |
Triple-Negative Breast Cancer | Hope S Rugo, MD
|
Jan 26, 2021 |
Triple-Negative Breast Cancer | Joyce O’Shaughnessy, MD
|
Jan 26, 2021 |
Triple-Negative Breast Cancer | P Kelly Marcom, MD
|
Jan 26, 2021 |
Lung Cancer | Addressing Current Questions and Controversies in the Management of Non-Small Cell Lung Cancer with an EGFR Mutation — Faculty Presentations
|
Jan 25, 2021 |
Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Triple-Negative Breast Cancer
|
Jan 23, 2021 |
Multiple Myeloma | Recent Advances in Medical Oncology: Multiple Myeloma
|
Jan 22, 2021 |
Lymphomas | Recent Advances in Medical Oncology: Hodgkin and Non-Hodgkin Lymphomas (Faculty Presentations)
|
Jan 21, 2021 |
Multiple Myeloma | Oncology Today with Dr Neil Love: Key Presentations on the Treatment of Multiple Myeloma from the 2020 ASH Annual Meeting
|
Jan 20, 2021 |
Ovarian Cancer | Oncology Today with Dr Neil Love: The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer
|
Jan 19, 2021 |
Metastatic Lung Cancer Special Nursing Edition Part 1 | Drs Suresh S Ramalingam and Gregory J Riely
|
Jan 16, 2021 |
Metastatic Lung Cancer Special Nursing Edition Part 2 | Nurse Practitioners Kelly EH Goodwin and Wendi S Lee
|
Jan 16, 2021 |
Hematologic Oncology | Recent Advances in Medical Oncology: Multiple Myeloma (Faculty Presentations)
|
Jan 15, 2021 |
Melanoma | Patterns of Care: Optimizing the Current Management of Melanoma with BRAF Mutation in the Real World
|
Jan 14, 2021 |
Lung Cancer Special Nursing Edition Part 1 | Drs Benjamin Levy and Stephen Liu
|
Jan 13, 2021 |
Lung Cancer Special Nursing Edition Part 2 | Nurse Practitioners Elizabeth Waxman and Beth Sandy
|
Jan 13, 2021 |
Prostate Cancer | Daniel P Petrylak, MD, Christopher Sweeney, MBBS and Robert Dreicer, MD, MS
|
Jan 11, 2021 |
ER-Positive Breast Cancer | Virginia Kaklamani, MD DSc
|
Jan 08, 2021 |
ER-Positive Breast Cancer | Sara M Tolaney, MD, MPH
|
Jan 08, 2021 |
Lung Cancer | Edward B Garon, MD, MS
|
Jan 05, 2021 |
Lung Cancer | David R Spigel, MD
|
Jan 05, 2021 |
Lung Cancer | Stephen V Liu, MD, PhD
|
Jan 05, 2021 |
Mesothelioma | Oncology Today with Dr Neil Love: Current Management of and Future Directions in Mesothelioma
|
Dec 30, 2020 |
Lung Cancer | Current Concepts and Recent Advances in Oncology Part 1: Lung Cancer
|
Dec 30, 2020 |
Hematologic Oncology | Current Concepts and Recent Advances in Oncology Part 2: Multiple Myeloma
|
Dec 30, 2020 |
Hematologic Oncology | Current Concepts and Recent Advances in Oncology Part 3: Chronic Lymphocytic Leukemia and Lymphomas
|
Dec 30, 2020 |
Gastrointestinal Cancers | Current Concepts and Recent Advances in Oncology Part 4: Gastrointestinal Cancer
|
Dec 30, 2020 |
Genitourinary Cancers | Current Concepts and Recent Advances in Oncology Part 5: Genitourinary Cancers
|
Dec 30, 2020 |
Gynecologic Cancer | Current Concepts and Recent Advances in Oncology Part 6: Gynecologic Cancer
|
Dec 30, 2020 |
Breast Cancer | Current Concepts and Recent Advances in Oncology Part 7: Breast Cancer
|
Dec 29, 2020 |
Follicular Lymphoma | Dissecting the Decision: Clinical and Nursing Investigators Provide Practical Perspectives on Key Issues in the Management of Follicular Lymphoma
|
Dec 28, 2020 |
Triple-Negative Breast Cancer | Hope S Rugo, MD and Joyce O’Shaughnessy, MD
|
Dec 23, 2020 |
Lung Cancer | Oncology Today with Dr Neil Love: The Role of Immunotherapy Combination Approaches in the Management of Metastatic Non-Small Cell Lung Cancer
|
Dec 22, 2020 |
Multitumor | Oncology Today with Dr Neil Love: The Role of PARP Inhibition in the Management of Common Cancers
|
Dec 18, 2020 |
HER2-Positive Breast Cancer | Lisa A Carey, MD and Ian E Krop, MD, PhD
|
Dec 18, 2020 |
Lung Cancer | What Advanced Practice Professionals Need to Know about Caring for Patients with Locally Advanced Non-Small Cell Lung Cancer
|
Dec 17, 2020 |
Chronic Lymphocytic Leukemia | Jeff Sharman, MD
|
Dec 17, 2020 |
Follicular Lymphoma | Julie M Vose, MD, MBA
|
Dec 17, 2020 |
Gastrointestinal Cancers | Johanna Bendell, MD
|
Dec 16, 2020 |
Gastrointestinal Cancers | Axel Grothey, MD
|
Dec 16, 2020 |
Gastrointestinal Cancers | Crystal Denlinger, MD
|
Dec 16, 2020 |
Gastrointestinal Cancers | Eric A Klein, MD
|
Dec 16, 2020 |
Bladder Cancer | Oncology Today with Dr Neil Love: Immune Checkpoint Inhibitors in Urothelial Bladder Carcinoma
|
Dec 15, 2020 |
Lung Cancer | Optimizing the Role of Radiation Oncologists and Other Multidisciplinary Team Members in the Management of Locally Advanced Non-Small Cell Lung Cancer
|
Dec 14, 2020 |
Gynecologic Cancers | Oncology Today with Dr Neil Love: Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers
|
Dec 11, 2020 |
Pancreatic Cancer | Oncology Today with Dr Neil Love: Management of Pancreatic Cancer
|
Dec 09, 2020 |
PARP Inhibitors Special Nursing Edition: Part 1 | Drs Kathleen Moore, Joyce O’Shaughnessy, Michael J Pishvaian and Emmanuel S Antonarakis
|
Dec 08, 2020 |
PARP Inhibitors Special Nursing Edition: Part 2 | Nurse Practitioners Deborah Wright, Jamie Carroll, Tammy Triglianos and Erika Meneely
|
Dec 08, 2020 |
Breast Cancer | Oncology Today with Dr Neil Love: Immune Checkpoint Inhibition in Breast Cancer
|
Dec 07, 2020 |
Multiple Myeloma | Exploring Clinical Investigator Perspectives on the Optimal Management of Multiple Myeloma
|
Dec 04, 2020 |
Gynecologic Cancer Special Nursing Edition: Part 1 | Drs David O’Malley and Shannon Westin
|
Dec 03, 2020 |
Gynecologic Cancer Special Nursing Edition: Part 2 | Nurse Practitioners Paula J Anastasia and Jennifer Filipi
|
Dec 03, 2020 |
Urothelial Bladder Carcinoma | Arjun Balar, MD
|
Dec 02, 2020 |
Urothelial Bladder Carcinoma | Thomas Powles, MBBS, MRCP, MD
|
Dec 02, 2020 |
Urothelial Bladder Carcinoma | Arlene Siefker-Radtke, MD
|
Dec 02, 2020 |
Multiple Myeloma | Oncology Today with Dr Neil Love: Novel Agents Under Investigation in Multiple Myeloma
|
Dec 01, 2020 |
Ovarian Cancer | Shannon N Westin, MD, MPH
|
Nov 25, 2020 |
Ovarian Cancer | Mansoor Raza Mirza, MD
|
Nov 25, 2020 |
Ovarian Cancer | Kathleen Moore, MD
|
Nov 25, 2020 |
Breast Cancer | Oncology Today with Dr Neil Love: Adjuvant Therapy for ER-Positive Breast Cancer
|
Nov 24, 2020 |
Colorectal Cancer | Beyond the Guidelines: Biomarker Assessment and Targeted Therapy for Metastatic Colorectal Cancer
|
Nov 23, 2020 |
Hepatocellular Carcinoma | Alan P Venook, MD
|
Nov 21, 2020 |
Hepatocellular Carcinoma | Philip A Philip, MD, PhD, FRCP
|
Nov 21, 2020 |
Pancreatic Cancer | Tanios Bekaii-Saab, MD
|
Nov 21, 2020 |
Pancreatic Cancer | Eileen M O’Reilly, MD
|
Nov 21, 2020 |
Lung Cancer | Addressing Current Questions and Controversies in the Management of Non-Small Cell Lung Cancer with an EGFR Mutation
|
Nov 20, 2020 |
Gastrointestinal Cancers | Recent Advances in Medical Oncology: Colorectal and Gastric Cancer
|
Nov 19, 2020 |
Lung Cancer | Oncology Today with Dr Neil Love: Management of Non-Small Cell Lung Cancer with ALK and ROS1 Rearrangements
|
Nov 18, 2020 |
Chronic Lymphocytic Leukemia | Exploring Clinical Investigator Perspectives on the Optimal Management of Chronic Lymphocytic Leukemia (for Medical and Hematologic Oncologists)
|
Nov 17, 2020 |
Gastroesophageal Cancers | Oncology Today with Dr Neil Love: Management of Gastroesophageal Cancers
|
Nov 16, 2020 |
Chimeric Antigen Receptor T-Cell Therapy | Sattva S Neelapu, MD
|
Nov 14, 2020 |
Chimeric Antigen Receptor T-Cell Therapy | Krishna Komanduri, MD
|
Nov 14, 2020 |
Chimeric Antigen Receptor T-Cell Therapy | Elizabeth Zerante, MS, AGACNP-BC
|
Nov 14, 2020 |
Chimeric Antigen Receptor T-Cell Therapy | Nikhil C Munshi, MD
|
Nov 14, 2020 |
Chimeric Antigen Receptor T-Cell Therapy | Tiffany Richards, PhD, ANP-BC, AOCNP
|
Nov 14, 2020 |
Chronic Lymphocytic Leukemia | Brad S Kahl, MD
|
Nov 13, 2020 |
Chronic Lymphocytic Leukemia | Jeff Sharman, MD
|
Nov 13, 2020 |
Chronic Lymphocytic Leukemia | Robin Klebig, APRN, CNP, AOCNP
|
Nov 13, 2020 |
Chronic Lymphocytic Leukemia | Amy Goodrich, CRNP
|
Nov 13, 2020 |
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer
|
Nov 12, 2020 |
Hepatocellular Carcinoma | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Hepatocellular Carcinoma
|
Nov 11, 2020 |
Lymphomas | Recent Advances in Medical Oncology: Hodgkin and Non-Hodgkin Lymphomas
|
Nov 10, 2020 |
Lung Cancer | What Oncology Nurses Need to Know: Management of Locally Advanced Non-Small Cell Lung Cancer
|
Nov 09, 2020 |
Hepatocellular Carcinoma and Pancreatic Cancer | Recent Advances in Medical Oncology: Hepatocellular Carcinoma and Pancreatic Cancer
|
Nov 06, 2020 |
Renal Cell Carcinoma | Oncology Today with Dr Neil Love: Renal Cell Carcinoma
|
Nov 05, 2020 |
Breast Cancer | Recent Advances in Medical Oncology: ER-Positive Breast Cancer
|
Nov 04, 2020 |
Prostate Cancer | What Oncology Nurses Need to Know: Role of Hormonal Therapy in the Management of Prostate Cancer
|
Nov 03, 2020 |
Lung Cancer | Recent Advances in Medical Oncology: Immunotherapy and Other Nontargeted Approaches for Lung Cancer
|
Nov 02, 2020 |
Acute Myeloid Leukemia | Oncology Today with Dr Neil Love: Acute Myeloid Leukemia with FLT3 Mutations
|
Oct 30, 2020 |
Urothelial Bladder Carcinoma | Recent Advances in Medical Oncology: Urothelial Bladder Carcinoma
|
Oct 29, 2020 |
Breast Cancer | Recent Advances in Medical Oncology: Triple-Negative Breast Cancer
|
Oct 28, 2020 |
Non-Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma
|
Oct 27, 2020 |
Chronic Lymphocytic Leukemia and Follicular Lymphoma | Key Questions and Emerging Research in the Management of Chronic Lymphocytic Leukemia and Follicular Lymphoma
|
Oct 26, 2020 |
Pancreatic Cancer | Oncology Today with Dr Neil Love: PARP Inhibition in the Management of Pancreatic Cancer Edition
|
Oct 23, 2020 |
Prostate Cancer | Patterns of Care: Understanding and Optimizing the Current Management of Metastatic Prostate Cancer in the Real World
|
Oct 22, 2020 |
Acute Myeloid Leukemia | Oncology Today with Dr Neil Love: Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy Edition
|
Oct 20, 2020 |
Multitumor | Virtual Molecular Tumor Board: Recognition and Management of Targetable Tumor Mutations in Less Common Cancer Types
|
Oct 20, 2020 |
Lung Cancer | Suresh Ramalingam, MD
|
Oct 19, 2020 |
Lung Cancer | Professor Solange Peters, MD, PhD
|
Oct 19, 2020 |
Lung Cancer | Alexander Drilon, MD
|
Oct 19, 2020 |
Lung Cancer | Recent Advances in Medical Oncology: Targeted Therapy for Lung Cancer
|
Oct 15, 2020 |
Chronic Lymphocytic Leukemia | Oncology Today with Dr Neil Love: Front-Line Treatment of Chronic Lymphocytic Leukemia Edition
|
Oct 14, 2020 |
Multitumor | Virtual Molecular Tumor Board: Identification of New and Emerging Genomic Alterations in Metastatic Non-Small Cell Lung Cancer
|
Oct 13, 2020 |
Ovarian Cancer | The Evolving Role of PARP Inhibition in the Management of Ovarian Cancer
|
Oct 12, 2020 |
Multitumor | Virtual Molecular Tumor Board: Role of Genomic Profiling for Patients with Solid Tumors and the Optimal Application of Available Testing Platforms
|
Oct 10, 2020 |
Hodgkin Lymphoma | Oncology Today with Dr Neil Love: Hodgkin Lymphoma Edition
|
Oct 09, 2020 |
Breast Cancer | Key Questions and Emerging Research in the Management of HER2-Positive Breast Cancer
|
Oct 07, 2020 |
Breast Cancer | Oncology Today with Dr Neil Love: PARP Inhibitors in Breast Cancer Edition
|
Oct 05, 2020 |
Prostate Cancer | Recent Advances in Medical Oncology: Prostate Cancer
|
Oct 01, 2020 |
Acute Myeloid Leukemia | Oncology Today with Dr Neil Love: Novel Induction and Maintenance Strategies in Acute Myeloid Leukemia Edition
|
Sep 30, 2020 |
Prostate Cancer | Oncology Grand Rounds Series: Part 11 — Prostate Cancer (Webinar Proceedings)
|
Sep 29, 2020 |
Bladder Cancer | Oncology Grand Rounds Series: Part 8 — Urothelial Bladder Carcinoma (Webinar Proceedings)
|
Sep 29, 2020 |
Myeloproliferative Neoplasms | Oncology Today with Dr Neil Love: Myeloproliferative Neoplasms Edition
|
Sep 25, 2020 |
Acute Myeloid Leukemia | Acute Myeloid Leukemia and the General Medical Oncologist: New Agents and Treatment Strategies, Particularly for Older Patients
|
Sep 24, 2020 |
Gynecologic Cancers | Oncology Grand Rounds Series: Part 5 — Gynecologic Cancers (Webinar Proceedings)
|
Sep 23, 2020 |
Multitumor | Oncology Grand Rounds Series: Part 10 — PARP Inhibition in the Management of Common Cancers (Webinar Proceedings)
|
Sep 23, 2020 |
Ovarian Cancer | Ursula Matulonis, MD
|
Sep 22, 2020 |
Breast Cancer | Hope Rugo, MD
|
Sep 22, 2020 |
Pancreatic Cancer | Philip Philip, MD, PhD, FRCP
|
Sep 22, 2020 |
Prostate Cancer | Maha Hussain, MD, FACP, FASCO
|
Sep 22, 2020 |
Lung Cancer | Ramaswamy Govindan, MD
|
Sep 21, 2020 |
Lung Cancer | Leora Horn, MD, MSc
|
Sep 21, 2020 |
Lung Cancer | Edward Garon, MD, MS
|
Sep 21, 2020 |
Lung Cancer | John Heymach, MD, PhD
|
Sep 21, 2020 |
Lung Cancer | Julie R Brahmer, MD, MSc
|
Sep 21, 2020 |
Lung Cancer | Benjamin Levy, MD
|
Sep 21, 2020 |
Lung Cancer | Hossein Borghaei, DO, MS
|
Sep 21, 2020 |
Lung Cancer | Melissa Johnson, MD
|
Sep 21, 2020 |
Melanoma | Professor Georgina Long, AO, BSc, PhD, MBBS
|
Sep 18, 2020 |
Melanoma | Michael B Atkins, MD
|
Sep 18, 2020 |
Melanoma | Jason J Luke, MD
|
Sep 18, 2020 |
Lung Cancer | Oncology Today with Dr Neil Love: EGFR Mutation-Positive Non-Small Cell Lung Cancer Edition
|
Sep 17, 2020 |
Multiple Myeloma | Oncology Today with Dr Neil Love: Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Edition
|
Sep 16, 2020 |
Urothelial Bladder Carcinoma | Oncology Today with Dr Neil Love: Immunotherapy for Urothelial Bladder Carcinoma Edition
|
Sep 11, 2020 |
Cutaneous Squamous Cell Carcinoma | Oncology Today with Dr Neil Love: Cutaneous Squamous Cell Carcinoma Edition
|
Sep 04, 2020 |
Lung Cancer | Oncology Grand Rounds Series: Part 6 — Metastatic Lung Cancer
|
Sep 03, 2020 |
Gastrointestinal Cancers | Oncology Grand Rounds Series: Part 2 — Gastrointestinal Cancers (Webinar Proceedings)
|
Sep 01, 2020 |
Chimeric Antigen Receptor T-Cell Therapy | Oncology Grand Rounds Series: Part 9 — Chimeric Antigen Receptor T-Cell Therapy (Webinar Proceedings)
|
Aug 28, 2020 |
Lung | COVID-19 and Lung Cancer: What We Know, What We Don’t Know and What It All Means for Current Patient Care
|
Aug 27, 2020 |
Multitumor | Data + Perspectives: Clinical Investigators Explore the Biology Underlying the Role of PARP Inhibition in the Management of Common Cancers
|
Aug 20, 2020 |
Follicular Lymphoma | Oncology Today with Dr Neil Love: Follicular Lymphoma Edition
|
Aug 18, 2020 |
Hodgkin and Non-Hodgkin Lymphomas | Michael Williams, MD, ScM
|
Aug 17, 2020 |
Hodgkin and Non-Hodgkin Lymphomas | Craig Moskowitz, MD
|
Aug 17, 2020 |
Hodgkin and Non-Hodgkin Lymphomas | Mollie Moran, APRN-CNP, AOCNP #1
|
Aug 17, 2020 |
Hodgkin and Non-Hodgkin Lymphomas | Mollie Moran, APRN-CNP, AOCNP #2
|
Aug 17, 2020 |
Hodgkin and Non-Hodgkin Lymphomas | Kim Leake, MSN, FNP-C #1
|
Aug 17, 2020 |
Hodgkin and Non-Hodgkin Lymphomas | Kim Leake, MSN, FNP-C #2
|
Aug 17, 2020 |
Hodgkin and Non-Hodgkin Lymphomas | Kim Leake, MSN, FNP-C #3
|
Aug 17, 2020 |
Melanoma | Recent Advances in Medical Oncology: Melanoma
|
Aug 14, 2020 |
Bladder Cancer | Arjun Balar, MD
|
Aug 13, 2020 |
Bladder Cancer | Siamak Daneshmand, MD
|
Aug 13, 2020 |
Bladder Cancer | Ashish M Kamat, MD, MBBS
|
Aug 13, 2020 |
Bladder Cancer | Jonathan E Rosenberg, MD
|
Aug 13, 2020 |
Bladder Cancer | The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer
|
Aug 13, 2020 |
COVID-19 and Management of Patients with Lung Cancer - Interview with Stephen V Liu, MD, PhD
|
Aug 11, 2020 |
COVID-19 and Management of Patients with Breast Cancer - Interview with Tiffany A Traina, MD
|
Aug 10, 2020 |
COVID-19 and Management of Patients with Gastrointestinal Cancers - Interview with Tanios Bekaii-Saab, MD
|
Aug 09, 2020 |
COVID-19 and Management of Patients with Genitourinary Cancers - Interview with William K Oh, MD
|
Aug 08, 2020 |
Chronic Lymphocytic Leukemia | Oncology Grand Rounds Series: Part 4 — Chronic Lymphocytic Leukemia (Webinar Proceedings)
|
Aug 07, 2020 |
Hodgkin and Non-Hodgkin Lymphomas | Oncology Grand Rounds Series: Part 3 — Hodgkin and Non-Hodgkin Lymphomas (Webinar Proceedings)
|
Aug 06, 2020 |
Colorectal Cancer | Oncology Today with Dr Neil Love: Colorectal Cancer Edition
|
Aug 04, 2020 |
Breast Cancer | Joyce O’Shaughnessy, MD
|
Jul 31, 2020 |
Breast Cancer | Marissa Marti, APRN, AGNP-C, AOCNP #1
|
Jul 31, 2020 |
Breast Cancer | Marissa Marti, APRN, AGNP-C, AOCNP #2
|
Jul 31, 2020 |
Breast Cancer | Daniel G Pizana, MSN-FNP, OCN
|
Jul 31, 2020 |
Breast Cancer | Virginia Kaklamani, MD, DSc
|
Jul 31, 2020 |
Gastrointestinal Cancers | Oncology Grand Rounds Series: Part 2 — Gastrointestinal Cancers (Webinar Proceedings)
|
Jul 28, 2020 |
Gynecologic Oncology | Interview with Ursula Matulonis, MD
|
Jul 27, 2020 |
Gynecologic Oncology | Interview with Michael Birrer, MD, PhD
|
Jul 27, 2020 |
Gynecologic Oncology | Interview with Krishnansu Tewari, MD
|
Jul 27, 2020 |
Gynecologic Oncology | Interview with David O’Malley, MD
|
Jul 27, 2020 |
Gynecologic Oncology | Ursula Matulonis, MD
|
Jul 23, 2020 |
Gynecologic Oncology | Michael Birrer, MD, PhD
|
Jul 23, 2020 |
Gynecologic Oncology | Krishnansu Tewari, MD
|
Jul 23, 2020 |
Gynecologic Oncology | David O’Malley, MD
|
Jul 23, 2020 |
Gynecologic Cancers | Data + Perspectives: The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in the Management of Gynecologic Cancers
|
Jul 22, 2020 |
Breast Cancer | Oncology Grand Rounds Series: Part 1 — Breast Cancer (Webinar Proceedings)
|
Jul 16, 2020 |
Gynecologic Oncology | Interview with Kathleen Moore, MD
|
Jul 14, 2020 |
Gynecologic Oncology | Interview with Joyce Liu, MD, MPH
|
Jul 14, 2020 |
Gynecologic Oncology | Interview with Robert Coleman, MD
|
Jul 14, 2020 |
Gynecologic Oncology | Interview with Stephanie Lheureux, MD, PhD
|
Jul 14, 2020 |
Gynecologic Oncology | Joyce Liu, MD, MPH
|
Jul 13, 2020 |
Gynecologic Oncology | Kathleen Moore, MD
|
Jul 13, 2020 |
Gynecologic Oncology | Robert Coleman, MD
|
Jul 13, 2020 |
Gynecologic Oncology | Stephanie Lheureux, MD, PhD
|
Jul 13, 2020 |
Ovarian Cancer | Beyond the Guidelines: Perspectives on the Role of PARP Inhibition in the Management of Ovarian Cancer
|
Jul 06, 2020 |
CLL | Understanding the Impact of COVID-19 on the Care of Patients with Chronic Lymphocytic Leukemia
|
Jun 24, 2020 |
Lung Cancer | Roundtable Discussion with Drs John Heymach, Leora Horn, Melissa Johnson and Benjamin Levy
|
Jun 17, 2020 |
Lung Cancer | Roundtable Discussion with Drs Hossein Borghaei, Julie Brahmer, Edward Garon and Ramaswamy Govindan
|
Jun 17, 2020 |
Lung Cancer | Biomarker Assessment and Targeted Treatment of Nonsquamous Non-Small Cell Lung Cancer
|
Apr 30, 2020 |
Lung Cancer | Matthew Gubens, MD, MS
|
Apr 30, 2020 |
Lung Cancer | Geoffrey R Oxnard, MD
|
Apr 30, 2020 |
Lung Cancer | Heather Wakelee, MD
|
Apr 30, 2020 |
Lung Cancer | Justin F Gainor, MD
|
Apr 30, 2020 |
Prostate Cancer | Exploring the Current and Future Role of PARP Inhibition in the Management of Prostate Cancer
|
Apr 20, 2020 |
Prostate Cancer | Emmanuel S Antonarakis, MD
|
Apr 20, 2020 |
Prostate Cancer | A Oliver Sartor, MD
|
Apr 20, 2020 |
Prostate Cancer | Neeraj Agarwal, MD
|
Apr 20, 2020 |
Renal Cell Carcinoma | Consensus or Controversy? Clinical Investigators Discuss the Optimal Management of Metastatic Renal Cell Carcinoma
|
Apr 15, 2020 |
Hepatocellular Carcinoma | James J Harding, MD
|
Apr 13, 2020 |
Hepatocellular Carcinoma | Tim Greten, MD
|
Apr 13, 2020 |
B-Cell Lymphomas | Novel and Emerging Therapeutic Strategies in the Management of Select B-Cell Lymphomas
|
Apr 11, 2020 |
Second Annual Miami General Medical Oncology Symposium: Part 1 — Keynote Session: Chronic Lymphocytic Leukemia
|
Apr 10, 2020 |
Second Annual Miami General Medical Oncology Symposium: Part 2 — Gastrointestinal Cancers
|
Apr 10, 2020 |
Second Annual Miami General Medical Oncology Symposium: Part 3 — Dermatologic Cancers
|
Apr 10, 2020 |
Second Annual Miami General Medical Oncology Symposium: Part 4 — Hodgkin and Non-Hodgkin Lymphomas
|
Apr 09, 2020 |
Second Annual Miami General Medical Oncology Symposium: Part 5 — Acute Leukemias
|
Apr 09, 2020 |
Second Annual Miami General Medical Oncology Symposium: Part 6 — Gynecologic Cancers
|
Apr 09, 2020 |
Second Annual Miami General Medical Oncology Symposium: Part 7 — Breast Cancer
|
Apr 09, 2020 |
Second Annual Miami General Medical Oncology Symposium: Part 8 — Genitourinary Cancers
|
Apr 09, 2020 |
Second Annual Miami General Medical Oncology Symposium: Part 9 — Head and Neck Cancer
|
Apr 09, 2020 |
Second Annual Miami General Medical Oncology Symposium: Part 10 — Multiple Myeloma
|
Apr 08, 2020 |
Second Annual Miami General Medical Oncology Symposium: Part 11 — Lung Cancer
|
Apr 08, 2020 |
Year in Review Proceedings Part 1: Lung Cancer
|
Apr 07, 2020 |
Year in Review Proceedings Part 2: Acute Leukemias
|
Apr 07, 2020 |
Year in Review Proceedings Part 3: Lymphomas and Chronic Lymphocytic Leukemia
|
Apr 07, 2020 |
Year in Review Proceedings Part 4: Gastrointestinal Cancers
|
Apr 07, 2020 |
Year in Review Proceedings Part 5: Genitourinary Cancers
|
Apr 06, 2020 |
Year in Review Proceedings Part 6: Gynecologic Cancers
|
Apr 06, 2020 |
Year in Review Proceedings Part 7: Breast Cancer
|
Apr 06, 2020 |
Prostate Cancer | Addressing Current Questions and Controversies in the Management of Prostate Cancer
|
Apr 02, 2020 |
Prostate Cancer | Maha Hussain, MD, FACP, FASCO
|
Mar 31, 2020 |
Prostate Cancer | Karim Fizazi, MD, PhD
|
Mar 31, 2020 |
Urothelial Bladder Carcinoma | Data + Perspectives: Clinical Investigators Discuss the Optimal Management of Urothelial Bladder Carcinoma
|
Mar 26, 2020 |
Acute Myeloid Leukemia | Daniel A Pollyea, MD, MS
|
Mar 26, 2020 |
Acute Myeloid Leukemia | Richard M Stone
|
Mar 26, 2020 |
AML | Data + Perspectives: Exploring the Role of Novel Agents and Emerging Strategies in the Management of Acute Myeloid Leukemia
|
Mar 24, 2020 |
Hepatobiliary Cancers | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Hepatobiliary Cancers
|
Mar 23, 2020 |
Colorectal, Gastroesophageal and Pancreatic Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Colorectal, Gastroesophageal and Pancreatic Cancer
|
Mar 19, 2020 |
Lung Cancer | iJournal Club: Optimizing Therapy for Patients with Metastatic Squamous Cell Carcinoma of the Lung
|
Mar 18, 2020 |
Acute Myeloid Leukemia | Exploring Current Management Paradigms for Acute Myeloid Leukemia in Patients Not Eligible for Intensive Therapy
|
Mar 16, 2020 |
Lung Cancer | D Ross Camidge, MD, PhD
|
Mar 12, 2020 |
Breast Cancer | Visiting Professors: Investigator Perspectives on Recently Approved and Emerging Strategies in the Management of Breast Cancer
|
Mar 12, 2020 |
ER-Positive Breast Cancer | Data + Perspectives: Clinical Investigators Explore the Current and Future Management of ER-Positive Breast Cancer — A Special Video Supplement
|
Mar 11, 2020 |
ER-Positive Breast Cancer | Data + Perspectives: Clinical Investigators Explore the Current and Future Management of ER-Positive Breast Cancer
|
Mar 09, 2020 |
HER2-Positive Breast Cancer | Data + Perspectives: Clinical Investigators Explore the Current and Future Management of HER2-Positive Breast Cancer
|
Mar 06, 2020 |
Triple-Negative Breast Cancer | Data + Perspectives: Clinical Investigators Explore the Current and Future Management of Triple-Negative Breast Cancer
|
Mar 03, 2020 |
Acute Leukemias | Alexander Perl, MD
|
Feb 26, 2020 |
Acute Leukemias | Eunice Wang, MD
|
Feb 26, 2020 |
Lymphomas and Chronic Lymphocytic Leukemia | Addressing Current Questions and Controversies in the Management of Lymphomas and Chronic Lymphocytic Leukemia
|
Feb 24, 2020 |
Multiple Myeloma, Amyloidosis and Waldenström Macroglobulinemia | Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Amyloidosis and Waldenström Macroglobulinemia
|
Feb 24, 2020 |
Lung Cancer and CNS Metastases| Gregory J Riely, MD, PhD
|
Feb 19, 2020 |
NSCLC | Consensus or Controversy? The Integration of Novel Therapies into the Interdisciplinary Management of Non-Small Cell Lung Cancer with CNS Metastases
|
Feb 18, 2020 |
Multitumor | Genomic Assays in the “Real” Oncology World — Part 1: Exploring the Role of Genomic Testing in Guiding Treatment for Patients with Advanced Breast, Colorectal and Prostate Cancers
|
Feb 13, 2020 |
Multitumor | Genomic Assays in the “Real” Oncology World — Part 2: Exploring the Role of Genomic Testing in Guiding Treatment for Patients with Advanced Breast, Colorectal and Prostate Cancers
|
Feb 13, 2020 |
Oncology Nursing Proceedings Part 9: Lung Cancer
|
Feb 05, 2020 |
Oncology Nursing Proceedings Part 8: Gynecologic Cancers
|
Feb 05, 2020 |
Oncology Nursing Proceedings Part 7: Melanoma
|
Feb 05, 2020 |
Oncology Nursing Proceedings Part 6: Breast Cancer
|
Feb 05, 2020 |
Oncology Nursing Proceedings Part 5: Prostate Cancer, Renal Cell Carcinoma and Urothelial Bladder Cancer
|
Feb 05, 2020 |
Oncology Nursing Proceedings Part 4: Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Hematologic Disorder-Related Anemia
|
Feb 04, 2020 |
Oncology Nursing Proceedings Part 3: Chronic Lymphocytic Leukemia and Hodgkin and Non-Hodgkin Lymphomas
|
Feb 04, 2020 |
Oncology Nursing Proceedings Part 2: Colorectal, Gastric, Hepatocellular and Pancreatic Cancers
|
Feb 04, 2020 |
Oncology Nursing Proceedings Keynote (Part 1): Revolutionary Strides in the Management of Acute Myeloid Leukemia
|
Feb 04, 2020 |
Pancreatic Cancer | Michael J Pishvaian, MD, PhD
|
Jan 24, 2020 |
Pancreatic Cancer | Talia Golan, MD
|
Jan 24, 2020 |
Soft Tissue Sarcoma | Visiting Professors: Investigator Perspectives on the Management of Soft Tissue Sarcoma
|
Jan 09, 2020 |
Multitumor | Year in Review: Proceedings from a Multitumor Regional Symposium Focused on the Application of Emerging Research Information to the Care of Patients with Common Cancers
|
Jan 06, 2020 |
Gastrointestinal Cancers | Novel and Emerging Therapeutic Strategies in the Management of Select Gastrointestinal Cancers
|
Jan 03, 2020 |
Metastatic Lung Cancer | Consensus or Controversy? Addressing Practical Clinical Questions Across the Metastatic Lung Cancer Continuum
|
Dec 19, 2019 |
Ovarian Cancer | Visiting Professors: Investigator Perspectives on the Current and Future Role of PARP Inhibition in the Management of Ovarian Cancer
|
Dec 17, 2019 |
SCLC | Meet The Professors: Clinical Investigators Provide Perspectives on the Integration of Immune Checkpoint Inhibitors into the Management of Small Cell Lung Cancer
|
Dec 11, 2019 |
NSCLC | Consensus or Controversy? Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Locally Advanced Non-Small Cell Lung Cancer
|
Dec 02, 2019 |
Melanoma | Oncology Today with Dr Neil Love: Melanoma Edition — Faculty Presentations
|
Nov 27, 2019 |
Melanoma | Oncology Today with Dr Neil Love: Melanoma Edition
|
Nov 27, 2019 |
Breast Cancer | Hope S Rugo, MD
|
Nov 21, 2019 |
Breast Cancer | Melinda Telli, MD
|
Nov 21, 2019 |
CLL | Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Chronic Lymphocytic Leukemia
|
Nov 15, 2019 |
Breast Cancer | Charles E Geyer Jr, MD
|
Nov 04, 2019 |
Breast Cancer | Tari A King, MD
|
Nov 04, 2019 |
Breast Cancer | Matthew Goetz, MD
|
Oct 28, 2019 |
Breast Cancer | Virginia Kaklamani, MD, DSc
|
Oct 28, 2019 |
Lung Cancer | Novel and Emerging Therapeutic Strategies in the Management of Non-Small Cell Lung Cancer
|
Sep 30, 2019 |
Chronic Lymphocytic Lymphoma | Professor Dr Stephan Stilgenbauer
|
Sep 25, 2019 |
Chronic Lymphocytic Lymphoma | Jennifer Woyach, MD
|
Sep 25, 2019 |
Follicular Lymphoma | Visiting Professors: Selection and Sequencing of Systemic Therapy in the Management of Follicular Lymphoma
|
Sep 13, 2019 |
Breast Cancer | Ian E Krop, MD, PhD
|
Sep 09, 2019 |
Breast Cancer | Sara Hurvitz, MD
|
Sep 09, 2019 |
Breast Cancer | Oncology Today with Dr Neil Love: Use of Genomic Classifiers to Inform Clinical Decision-Making for Patients with Early Breast Cancer
|
Sep 05, 2019 |
Multiple Myeloma | S Vincent Rajkumar, MD
|
Sep 04, 2019 |
Multiple Myeloma | Paul G Richardson, MD
|
Sep 04, 2019 |
Multiple Myeloma | Nina Shah, MD
|
Sep 04, 2019 |
Multiple Myeloma | Irene M Ghobrial, MD
|
Sep 04, 2019 |
Chronic Lymphocytic Leukemia | William G Wierda, MD, PhD
|
Aug 20, 2019 |
Chronic Lymphocytic Leukemia | Anthony R Mato, MD, MSCE
|
Aug 20, 2019 |
Lung Cancer | Benjamin Levy, MD and Raymond Lobins, DO
|
Aug 02, 2019 |
Lung Cancer | Leora Horn, MD, MSc and Yanjun Ma, MD
|
Aug 02, 2019 |
Hematologic Oncology | Sonali M Smith, MD
|
Jul 31, 2019 |
Hematologic Oncology | Noopur Raje, MD
|
Jul 31, 2019 |
Hematologic Oncology | Meet the Professors: Clinical Investigator Perspectives on Key Questions and Emerging Research in the Management of Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma
|
Jul 30, 2019 |
Renal Cell Carcinoma | Oncology Today with Dr Neil Love: Renal Cell Carcinoma Edition
|
Jul 25, 2019 |
Myeloproliferative Neoplasms | Oncology Today with Dr Neil Love: Myeloproliferative Neoplasms Edition
|
Jul 25, 2019 |
Anemia | Rami Komrokji, MD
|
Jul 17, 2019 |
Anemia | Maria-Domenica Cappellini, MD
|
Jul 17, 2019 |
Melanoma | Breakfast with the Investigators: Management of Melanoma
|
Jul 16, 2019 |
Breast Cancer | Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications
|
Jul 12, 2019 |
Gastrointestinal Cancers | Addressing Current Questions and Controversies in the Management of Gastrointestinal Cancers
|
Jul 11, 2019 |
Ovarian Cancer | Breakfast with the Investigators: Exploring the Role of PARP Inhibition in the Management of Ovarian Cancer
|
Jul 10, 2019 |
Lung Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Lung Cancer
|
Jul 09, 2019 |
Bladder Cancer | Breakfast with the Investigators: Current and Future Management of Urothelial Bladder Carcinoma
|
Jul 05, 2019 |
Hematology Oncology | Oncology Today with Dr Neil Love: Waldenström Macroglobulinemia Edition
|
Jul 02, 2019 |
Breast Cancer | Interactive Tumor Panel: Clinical Investigators Discuss Emerging Research and Actual Cases of Patients with Breast Cancer
|
Jun 28, 2019 |
Ovarian Cancer | Bradley J Monk, MD
|
Jun 27, 2019 |
Ovarian Cancer | Professor Jonathan A Ledermann
|
Jun 27, 2019 |
Oncology Grand Rounds Series: Part 6 — Emerging Strategies in Non-Small Cell Lung Cancer
|
Jun 25, 2019 |
Oncology Grand Rounds Series: Part 5 — Breast Cancer
|
Jun 25, 2019 |
Oncology Grand Rounds Series: Part 4 — Chronic Lymphocytic Leukemia
|
Jun 25, 2019 |
Oncology Grand Rounds Series: Part 3 — Locally Advanced Non-Small Cell Lung Cancer
|
Jun 25, 2019 |
Oncology Grand Rounds Series: Part 2 — Hodgkin and Non-Hodgkin Lymphomas
|
Jun 25, 2019 |
Oncology Grand Rounds Series: Part 1 — Gastrointestinal Cancers
|
Jun 24, 2019 |
Gynecologic Oncology | Addressing Current Questions and Emerging Considerations with the Use of PARP Inhibitors in the Management of Ovarian Cancer
|
Jun 18, 2019 |
Gynecologic Oncology | Data + Perspectives: Clinical Investigators Explore Emerging Research and Actual Patients with Uterine Sarcomas
|
Jun 15, 2019 |
Multitumor | PARP Inhibition in Four Common Cancers: Biology, Clinical Research Database and Therapeutic Strategy
|
Jun 13, 2019 |
Lung Cancer | Leveraging the Immune System for Therapeutic Benefit in Non-Small Cell Lung Cancer: Scientific Insights, Clinical Applications and Future Directions
|
Jun 10, 2019 |
Gynecologic Oncology | Novel Agents and Emerging Strategies in the Management of Gynecologic Cancers
|
Jun 07, 2019 |
Lung Cancer | Andreas Rimner, MD
|
Jun 05, 2019 |
Lung Cancer | Corey J Langer, MD
|
Jun 05, 2019 |
Genitourinary Cancers | Emmanuel S Antonarakis, MD
|
Jun 03, 2019 |
Genitourinary Cancers | Matthew R Smith, MD, PhD
|
Jun 03, 2019 |
Breast Cancer | Dissecting the Decision: Optimizing the Use of CDK4/6 Inhibitors in the Management of ER-Positive, HER2-Negative Metastatic Breast Cancer
|
May 30, 2019 |
Colorectal | Investigator Perspectives on the Current Utility of Validated and Emerging Biomarkers to Guide Treatment Decision-Making for Patients with Metastatic Colorectal Cancer
|
May 21, 2019 |
Hematologic Oncology | Aaron T Gerds, MD, MS
|
May 03, 2019 |
Hematologic Oncology | Ruben A Mesa, MD
|
May 03, 2019 |
Multitumor | Keynote Session: Chimeric Antigen Receptor T-Cell Therapy
|
Apr 29, 2019 |
Multitumor | Colorectal and Gastric Cancer
|
Apr 29, 2019 |
Multitumor | Hepatocellular Carcinoma
|
Apr 29, 2019 |
Multitumor | Melanoma
|
Apr 26, 2019 |
Multitumor | Chronic Lymphocytic Leukemia
|
Apr 26, 2019 |
Multitumor | Hodgkin and Non-Hodgkin Lymphomas
|
Apr 26, 2019 |
Multitumor | Ovarian Cancer
|
Apr 26, 2019 |
Multitumor | Pancreatic Cancer
|
Apr 25, 2019 |
Multitumor | ER-Positive, HER2-Negative Breast Cancer
|
Apr 25, 2019 |
Multitumor | HER2-Positive and Triple-Negative Breast Cancer
|
Apr 25, 2019 |
Multitumor | Acute Myeloid Leukemia
|
Apr 25, 2019 |
Multitumor | Prostate Cancer
|
Apr 24, 2019 |
Multitumor | Renal Cell and Bladder Cancer
|
Apr 24, 2019 |
Multitumor | Targeted Treatment of Lung Cancer
|
Apr 24, 2019 |
Multitumor | Immune Checkpoint Inhibitors in Lung Cancer
|
Apr 24, 2019 |
Prostate | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Prostate Cancer
|
Apr 16, 2019 |
Leukemias | Mark Levis, MD, PhD
|
Apr 08, 2019 |
Leukemias | Farhad Ravandi, MD
|
Apr 08, 2019 |
GI | Meet The Professors: Clinical Investigator Perspectives on Key Questions and Emerging Research in the Management of Colorectal, Gastric and Hepatocellular Cancer
|
Mar 29, 2019 |
Pancreatic | Cases from the Community: Clinical Investigators Provide Perspectives on Actual Patients with Pancreatic Cancer
|
Mar 22, 2019 |
Breast | Oncology Today with Dr Neil Love: Breast Cancer Edition
|
Mar 20, 2019 |
Lung | Interview with Suresh S Ramalingam, MD
|
Mar 19, 2019 |
Lung | Interview with Jamie E Chaft, MD
|
Mar 19, 2019 |
Pancreatic | Interview with Andrew H Ko, MD
|
Mar 14, 2019 |
Pancreatic | Interview with E Gabriela Chiorean, MD
|
Mar 14, 2019 |
Multi | Interview with Hope Rugo, MD
|
Mar 01, 2019 |
Multi | Interview with Gary Lyman, MD, MPH
|
Mar 01, 2019 |
Multi | Interview with Sanjiv Agarwala, MD
|
Mar 01, 2019 |
Derm | Interview with Prof Caroline Robert, MD, PhD
|
Feb 25, 2019 |
Derm | Interview with Mario Sznol, MD
|
Feb 25, 2019 |
Derm | Interview with Karl Lewis, MD
|
Feb 25, 2019 |
Derm | Interview with Michael A Postow, MD
|
Feb 25, 2019 |
Hem | Oncology Today with Dr Neil Love: Diffuse Large B-Cell Lymphoma Edition
|
Feb 22, 2019 |
GI | Oncology Today with Dr Neil Love: Gastrointestinal Cancers Edition 2019 — Gastric Cancer
|
Feb 18, 2019 |
Hem | Interview with Radhakrishnan Ramchandren, MD
|
Feb 14, 2019 |
Hem | Interview with David J Straus, MD
|
Feb 14, 2019 |
GI | Oncology Today with Dr Neil Love: Gastrointestinal Cancers Edition 2019 — Hepatocellular Carcinoma
|
Feb 11, 2019 |
Hem | Interview with Gilles A Salles, MD, PhD
|
Feb 06, 2019 |
Hem | Interview with Nathan H Fowler, MD
|
Feb 06, 2019 |
GI | Oncology Today with Dr Neil Love: Gastrointestinal Cancers Edition 2019 — Colorectal Cancer
|
Feb 01, 2019 |
Breast | Addressing Current Questions and Controversies in the Management of Early and Advanced Breast Cancer
|
Jan 29, 2019 |
Lung | Year in Review: On Demand — Significance and Relevance of Recent Data Sets and Publications in the Management of Lung Cancer
|
Jan 22, 2019 |
Hem | Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Waldenström Macroglobulinemia and Amyloidosis
|
Jan 17, 2019 |
Breast | Interview with Ingrid A Mayer, MD, MSCI
|
Jan 16, 2019 |
Breast | Interview with Daniel F Hayes, MD
|
Jan 16, 2019 |
Breast | Interview with Eric P Winer, MD
|
Jan 16, 2019 |
GI | Interview with Prof Eric Van Cutsem, MD, PhD
|
Jan 15, 2019 |
Hem | Addressing Current Questions and Controversies in the Management of Lymphomas and Chronic Lymphocytic Leukemia
|
Jan 14, 2019 |
Lung | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Application of Immune Checkpoint Inhibition in the Management of Metastatic Lung Cancer
|
Dec 31, 2018 |
Hem | Interview with Jennifer R Brown, MD, PhD
|
Dec 26, 2018 |
Hem | Interview with Prof John G Gribben, MD, DSc, FMedSci
|
Dec 26, 2018 |
Breast | Interview with Terry Mamounas, MD, MPH
|
Dec 23, 2018 |
Breast | Interview with Harold J Burstein, MD, PhD
|
Dec 23, 2018 |
Breast | Interview with Erica L Mayer, MD, MPH
|
Dec 18, 2018 |
Breast | Interview with Joyce O’Shaughnessy, MD
|
Dec 18, 2018 |
Multi | Year in Review: Proceedings from a Multitumor Regional Symposium Focused on the Application of Emerging Research Information to the Care of Patients with Common Cancers
|
Dec 13, 2018 |
Hem | Interview with Jorge E Cortes, MD
|
Dec 06, 2018 |
Hem | Interview with Daniel Pollyea, MD, MS
|
Dec 06, 2018 |
Hem | Hodgkin Lymphoma
|
Oct 31, 2018 |
Hem | Diffuse Large B-Cell Lymphoma
|
Oct 31, 2018 |
Hem | Mantle Cell Lymphoma
|
Oct 31, 2018 |
Hem | Follicular Lymphoma
|
Oct 31, 2018 |
Hem | Chronic Lymphocytic Leukemia
|
Oct 31, 2018 |
Lung | Interview with Justin F Gainor, MD
|
Oct 26, 2018 |
Lung | Interview with David R Spigel, MD
|
Oct 26, 2018 |
GI | Interview with Andrew X Zhu, MD, PhD
|
Oct 22, 2018 |
GI | Interview with Richard S Finn, MD
|
Oct 22, 2018 |
Lung | Interview with Martin Reck, MD, PhD
|
Oct 11, 2018 |
Lung | Interview with Geoffrey R Oxnard, MD
|
Oct 11, 2018 |
Hem | Acute Promyelocytic Leukemia (APL)
|
Oct 09, 2018 |
Hem | Acute Lymphoblastic Leukemia (ALL)
|
Oct 09, 2018 |
Hem | Acute Myeloid Leukemia (AML)
|
Oct 09, 2018 |
GI | Hepatocellular Carcinoma (HCC) (Dr O’Reilly)
|
Sep 28, 2018 |
GI | Pancreatic Cancer (Dr O’Reilly)
|
Sep 28, 2018 |
GI | Gastric Cancer (Dr Bekaii-Saab)
|
Sep 28, 2018 |
GI | Colorectal Cancer (CRC) (Dr Bekaii-Saab)
|
Sep 28, 2018 |
Breast | Role of Immune Checkpoint Inhibitors
|
Sep 25, 2018 |
Breast | PARP Inhibitors for Advanced Disease
|
Sep 25, 2018 |
Breast | Adjuvant Therapy for BC
|
Sep 25, 2018 |
Breast | mTOR Inhibitors and Antiandrogens for ER-Positive BC
|
Sep 25, 2018 |
Breast | CDK4/6 Inhibitors in the Treatment of ER-Positive, HER2-Negative Breast Cancer (BC)
|
Sep 25, 2018 |
Breast | Visiting Professors: Improving the Efficacy of Endocrine Treatment of Metastatic Breast Cancer
|
Sep 18, 2018 |
Hem | Dissecting the Decision: Documenting and Discussing the Clinical Practice Patterns of Hematologic Oncology Investigators in the Management of Mantle Cell Lymphoma
|
Sep 07, 2018 |
Hem | Dissecting the Decision: Documenting and Discussing the Clinical Practice Patterns of Hematologic Oncology Investigators in the Management of Chronic Lymphocytic Leukemia
|
Sep 04, 2018 |
Hem | Dissecting the Decision: Documenting and Discussing the Clinical Practice Patterns of Hematologic Oncology Investigators in the Management of Follicular Lymphoma
|
Aug 31, 2018 |
GI | An Evening with the Investigators: Perspectives on Key Questions and Emerging Research in the Management of Gastrointestinal Cancers
|
Aug 30, 2018 |
Breast | Consensus or Controversy? Clinical Investigators Provide Perspectives on Practical Issues and Ongoing Research Related to the Management of Breast Cancer
|
Aug 24, 2018 |
GU | Breakfast with the Investigators: Management of Renal Cell Carcinoma
|
Aug 08, 2018 |
Hem | Beyond the Guidelines: Investigator Perspectives on Current Clinical Issues and Ongoing Research in the Management of Lymphoma, Chronic Lymphocytic Leukemia and Multiple Myeloma
|
Aug 06, 2018 |
Gyn | Breakfast with the Investigators: New Agents and Strategies in the Management of Ovarian Cancer
|
Aug 03, 2018 |
Derm | Breakfast with the Investigators: Management of Melanoma
|
Aug 02, 2018 |
Lung | Cases from the Community: Clinical Investigators Provide Their Perspectives on Emerging Research and Actual Patients with Non-Small Cell Lung Cancer
|
Jul 31, 2018 |
Hem | Meet The Professors: Hodgkin Lymphoma Edition, 2018
|
Jul 30, 2018 |